OTUD6B-related neurodevelopmental disorder (intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies; IDDFSDA, MIM 617452) is an ultra-rare autosomal recessive multisystem disorder caused by biallelic variants in OTUD6B, which encodes an ovarian-tumor (OTU) domain deubiquitinating enzyme. The core clinical picture is global developmental delay and intellectual disability with seizures, a recognizable dysmorphic facial gestalt, poor pre- and postnatal growth, and characteristic distal limb findings (broad distal phalanges of thumbs and halluces, prominent interphalangeal joints, persistent fetal fingertip pads). Individuals with predicted loss-of-function alleles are more severely affected, with microcephaly, absent speech, hypotonia, feeding difficulties, structural brain abnormalities, and congenital heart disease; individuals carrying alleles with residual function can have mild to moderate intellectual disability with preserved speech and ambulation. Mechanistically, patient cells show reduced incorporation of 19S regulatory subunits into 26S proteasomes, decreased chymotrypsin-like proteasome activity, and accumulation of ubiquitin-protein conjugates, placing the disorder among the ubiquitin-proteasome system disorders of development.
Ask a research question about OTUD6B-Related Neurodevelopmental Disorder. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from OTUD6B-Related Neurodevelopmental Disorder:
name: OTUD6B-Related Neurodevelopmental Disorder
creation_date: "2026-08-01T00:00:00Z"
category: Mendelian
description: >-
OTUD6B-related neurodevelopmental disorder (intellectual developmental disorder
with dysmorphic facies, seizures, and distal limb anomalies; IDDFSDA, MIM 617452)
is an ultra-rare autosomal recessive multisystem disorder caused by biallelic
variants in OTUD6B, which encodes an ovarian-tumor (OTU) domain deubiquitinating
enzyme. The core clinical picture is global developmental delay and intellectual
disability with seizures, a recognizable dysmorphic facial gestalt, poor pre- and
postnatal growth, and characteristic distal limb findings (broad distal phalanges
of thumbs and halluces, prominent interphalangeal joints, persistent fetal
fingertip pads). Individuals with predicted loss-of-function alleles are more
severely affected, with microcephaly, absent speech, hypotonia, feeding
difficulties, structural brain abnormalities, and congenital heart disease;
individuals carrying alleles with residual function can have mild to moderate
intellectual disability with preserved speech and ambulation. Mechanistically,
patient cells show reduced incorporation of 19S regulatory subunits into 26S
proteasomes, decreased chymotrypsin-like proteasome activity, and accumulation
of ubiquitin-protein conjugates, placing the disorder among the ubiquitin-proteasome
system disorders of development.
notes: >-
Named-entity-confusion guardrail. This entry is anchored strictly on
MONDO:0044319 / OMIM:617452 / OTUD6B (HGNC:24281), confirmed by the MONDO
`RO:0004003` gene-association relation. It is deliberately NOT merged with
three closely named or closely related entities. (1) MONDO:0060596
"neurodevelopmental disorder with dysmorphic facies and distal limb
anomalies" is the BPTF-related disorder (NEDDFL) and is a different gene and
a different MONDO entity; PMID:33522091 describes that BPTF entity and is
therefore excluded from every OTUD6B claim in this entry, appearing only as
evidence on the BPTF differential_diagnoses record. (2) MONDO:0032855
"neurodevelopmental disorder with dysmorphic facies and distal skeletal
anomalies" is likewise a separate entity. (3) Other OTU-family
deubiquitinase disorders are distinct: OTUD5 causes an X-linked
multiple-congenital-anomaly/neurodevelopmental syndrome, OTUD7A lies in the
15q13.3 microdeletion interval, and OTUD1/OTUB1 appear in overlapping
ubiquitin-signalling literature without being the cause of this disorder.
Every citation used here was checked to name OTUD6B specifically. Most
OTUD6B PubMed hits are cancer-biology or lncRNA (OTUD6B-AS1) papers that are
unrelated to the Mendelian disorder and were excluded.
Frequency discipline. Frequency bands here come from exactly two denominator
sources, both recorded per phenotype in that phenotype's `notes:`. (1) The
HPO disease-annotation file (phenotype.hpoa, checked directly against the
current release) carries per-phenotype `n/m` counts for OMIM:617452 curated
from the founding cohort PMID:28343629, e.g. Seizure 12/12, Microcephaly
9/12, Generalized hypotonia 9/12, Feeding difficulties 9/12, Intrauterine
growth retardation 7/12, Long palpebral fissure 6/12, Broad thumb 6/12,
Atrial septal defect 3/6. (2) PMID:41188742 supplies an explicit denominator
for the ocular phenotype. Where neither source applies the band is omitted
rather than guessed. Important caveat on the HPOA counts: they derive from a
single, ascertainment-biased 2017 cohort weighted toward severe
loss-of-function genotypes, so they likely overstate severity across the full
allelic spectrum. HPOA records Severe intellectual disability as 12/12, which
is directly contradicted by the later mild cases (PMID:30364145,
PMID:34354232); this entry therefore models the broader HP:0001249
Intellectual disability rather than adopting the severe-ID annotation, and
bands should be read as cohort-specific rather than population estimates.
HPOA-annotated features not separately modeled here. phenotype.hpoa lists
additional terms for OMIM:617452 that are not given their own phenotype
entries: macrotia 7/12, short stature 7/12, decreased body weight 6/12, thin
upper lip vermilion 6/12, prominent nasal bridge 5/12, scoliosis 5/12,
retrognathia 4/12, overlapping toe 3/12, autistic behavior 3/12, hypoplasia
of the corpus callosum 3/12, short neck 3/12, highly arched eyebrow 3/12,
down-sloping shoulders 3/12, spastic tetraplegia 2/12, chronic constipation
2/12, sacral dimple 2/12, brachycephaly 1/12, plus unquantified terms
including inability to walk, ventriculomegaly, failure to thrive, hearing
impairment, cryptorchidism, and talipes equinovarus. The reason for the
omission is that these counts derive from the PMID:28343629 full-text table
rather than from its abstract, and this entry takes its snippets from
abstracts. That reason must not be overstated: references_cache/PMID_41188742.md
is cached as full text and does contain a 28-case aggregate table carrying
several of these rows (short stature 16/28, poor weight gain 14/28, scoliosis
8/22, cryptorchidism 7/24, abnormal cranial MRI 13/24). Those rows are
PDF-mangled and bundle several features per line, so they were judged too
unreliable to quote, but they do exist, and quoting the primary full text is
the right way to close this gap in a follow-up pass. Long philtrum was
previously listed here as unsupported by any cached abstract; that was wrong,
and it is now modeled as its own phenotype from the PMID:34680978 abstract.
Blended phenotypes and attribution discipline. Three reported probands carry
a second, independent pathogenic locus that contributes to the observed
picture: RP1L1 causing the retinal degeneration in PMID:34354232, a
heterozygous PKD1 variant contributing renal cystic disease in PMID:35707595,
and a ZMIZ1 splice variant in PMID:34680978. These are co-occurring
conditions, not OTUD6B modifiers. The RP1L1 retinal degeneration and the PKD1
renal cystic disease are therefore not attributed to OTUD6B at all. The
PMID:34680978 proband is handled differently, because that paper's authors
explicitly propose their facial findings as an OTUD6B phenotype expansion: the
Williams syndrome-like features (periorbital edema, hanging cheek, long and
smooth philtrum) and the polydactyly are curated, but every one of them
carries supports PARTIAL and a note naming the heterozygous ZMIZ1
c.1491 + 2T > C exon-14-skipping variant as an unresolved confounder, with a
cross-reference to the ZMIZ1 entry in differential_diagnoses.
Structured-source citations unavailable. ClinGen has a Definitive
gene-disease validity assertion for OTUD6B and syndromic intellectual
disability (assertion 3c60103c-7d9b-4dca-aa03-151130c5d6db, SOP10, AR,
Intellectual Disability and Autism Gene Curation Expert Panel, 2024-08-22),
and Orphanet codes this disorder as ORPHA:505237. Neither a `CGGV:` nor an
`ORPHA:` record could be generated into references_cache in this working
environment, and the relevant data MANIFEST pins are stale and
un-refreshable pending #7622, so no structured-source snippet is cited. The
gene-disease relationship is instead supported here by primary literature.
Not cited for snippets. PMID:31147255 (first Spanish case) and PMID:32181568
(Alkuraya, phenotypic-expansion comment) are genuine OTUD6B disorder reports
but have no abstract text in PubMed, so no verbatim snippet could be taken
from them; they are recorded in the top-level references block only.
disease_term:
preferred_term: OTUD6B-related neurodevelopmental disorder
term:
id: MONDO:0044319
label: intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
parents:
- Neurodevelopmental Disorder
- Autosomal Recessive Syndromic Intellectual Disability
synonyms:
- intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
- IDDFSDA
- OTUD6B-related syndrome
- OTUD6B-associated intellectual disability
classifications:
harrisons_chapter:
- classification_value: NEUROLOGIC
notes: >-
The dominant clinical burden is neurodevelopmental: global developmental
delay, intellectual disability, seizures, hypotonia, and structural brain
abnormalities.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
independent families with an intellectual disability syndrome associated
with seizures and dysmorphic features
explanation: >-
The defining cohort establishes intellectual disability and seizures as the
core presenting features, supporting a neurologic chapter assignment.
- classification_value: GENETICS_ENVIRONMENT_DISEASE
notes: >-
A monogenic, autosomal recessive Mendelian disorder diagnosed by exome or
genome sequencing.
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intellectual developmental disorder with dysmorphic facies, seizures, and
distal limb anomalies (IDDFSDA) is an autosomal recessive multisystem
disorder caused by compound heterozygous or homozygous variants in the gene
OTUD6B
explanation: >-
States the Mendelian, autosomal recessive, single-gene basis of the disorder.
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Disease requires biallelic (homozygous or compound heterozygous) OTUD6B
variants. Reported families include consanguineous pedigrees with homozygous
alleles and non-consanguineous pedigrees with compound heterozygous alleles.
Heterozygous carrier parents are unaffected. Recurrence risk for siblings of an
affected proband is 25 percent, and carrier testing plus genetic counseling are
indicated for at-risk relatives.
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
an autosomal recessive multisystem disorder caused by compound heterozygous
or homozygous variants in the gene OTUD6B
explanation: >-
Directly states the autosomal recessive, biallelic requirement, including both
the homozygous and compound heterozygous configurations.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The segregation in the family was confirmed by Sanger sequencing: the father
(I1) was carrier of the c.324+1G>C mutation whereas the mother (I2) was
heterozygous for c.405+1G>A.
explanation: >-
Documents biparental transmission of two different alleles to an affected
compound heterozygous child, with unaffected heterozygous carrier parents.
prevalence:
- population: Worldwide reported literature
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
Fewer than 30 individuals had been reported worldwide as of the 2025 Chinese
case report; that paper's own literature table enumerates 27 previously
reported cases plus its index case. No population-based prevalence study
exists. Orphanet assigns ORPHA:505237 a point-prevalence band of below 1 in
1,000,000, which would correspond to the BELOW_1_IN_1000000 class and a rate
of under 0.1 per 100,000; that band is recorded here as context only and is
not adopted as the structured value, because no ORPHA cache record could be
generated in this environment to carry a validated snippet (see the
entry-level notes and #7622). The measure actually asserted is therefore the
snippet-verifiable published case count.
evidence:
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
There have been < 30 reported cases globally without fundus and retinal
lesions.
explanation: >-
Provides the published worldwide case count supporting an ultra-rare
classification based on cases in the literature rather than a population rate.
pathophysiology:
- name: Biallelic OTUD6B Loss-of-Function Variants
biological_scale: MOLECULAR
description: >-
The disorder is initiated by inheritance of two damaging OTUD6B alleles. The
reported allelic spectrum includes nonsense alleles, canonical splice-donor
alleles that abolish normal splicing and trigger nonsense-mediated decay,
frameshift alleles, and rare missense alleles within the catalytic OTU domain.
genes:
- preferred_term: OTUD6B
term:
id: hgnc:24281
label: OTUD6B
downstream:
- target: Loss of OTUD6B Deubiquitinase Activity
description: >-
Damaging biallelic alleles remove or inactivate the OTU-domain
deubiquitinating enzyme encoded by OTUD6B.
causal_link_type: DIRECT
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our findings suggest a role for OTUD6B in proteasome function, establish
that defective OTUD6B function underlies a multisystemic human disorder
explanation: >-
The authors frame the disease as arising from defective OTUD6B function,
the direct consequence of the biallelic damaging alleles.
- target: Allele-Dependent Residual OTUD6B Function
description: >-
Because different alleles leave different amounts of functional protein or
differently destabilize the fold, the specific genotype sets the residual
activity available to the developing organism.
causal_link_type: DIRECT
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: >-
Our findings suggest that compound LOF and ultrarare missense variants may
be contribute to the underlying variability expressivity associated with
this disorder.
explanation: >-
Links the specific allele combination to the residual-function and
expressivity axis. The awkward phrasing is quoted verbatim from the
published abstract.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
independent families with an intellectual disability syndrome associated
with seizures and dysmorphic features
explanation: >-
Establishes biallelic OTUD6B variants as the initiating genetic lesion in the
original multi-family discovery cohort.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Data analysis highlighted the presence of two heterozygous variants affecting
exons 2 (c.324+1G>C) and 3 (c.405+1G>A) donor splice sites of the OTUD6B gene
explanation: >-
An independent replication family in which two canonical splice-donor alleles
constitute the biallelic lesion.
- name: Loss of OTUD6B Deubiquitinase Activity
biological_scale: MOLECULAR
description: >-
OTUD6B encodes a member of the ovarian tumor (OTU) domain subfamily of
deubiquitinating enzymes, which remove ubiquitin from substrate proteins and
thereby counterbalance E1/E2/E3 ubiquitin conjugation. Loss of this activity
removes a node of control over ubiquitin-dependent protein turnover, trafficking,
and signaling.
molecular_functions:
- preferred_term: cysteine-type deubiquitinase activity
term:
id: GO:0004843
label: cysteine-type deubiquitinase activity
modifier: DECREASED
biological_processes:
- preferred_term: protein deubiquitination
term:
id: GO:0016579
label: protein deubiquitination
modifier: DECREASED
downstream:
- target: Impaired 26S Proteasome Assembly
description: >-
Loss of OTUD6B activity is associated with defective incorporation of the 19S
regulatory particle into the mature 26S proteasome in patient cells.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Analysis of peripheral blood mononuclear cells from an affected subject
showed reduced incorporation of 19S subunits into 26S proteasomes
explanation: >-
Cells lacking functional OTUD6B show the 19S incorporation defect,
establishing the edge from lost deubiquitinase activity to impaired
proteasome assembly. The intermediate steps are not resolved.
- target: Dysregulated mTORC1-Linked Translation Initiation
description: >-
OTUD6B also acts on the translation initiation machinery downstream of mTORC1,
so its loss removes a second, proteasome-independent output.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
OTUD6B associates with the protein synthesis initiation complex and
modifies components of the 48S preinitiation complex.
explanation: >-
Establishes the physical and enzymatic link from OTUD6B to translation
initiation. PARTIAL because the work is in a cancer cell line rather than
a developmental model.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily
of deubiquitinating enzymes.
explanation: >-
Identifies the molecular function lost when OTUD6B is disrupted.
- reference: PMID:33421002
reference_title: "Studying OTUD6B-OTUB1 Protein-Protein Interaction by Low-Throughput GFP-Trap Assays and High-Throughput AlphaScreen Assays."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
we study the protein-protein interaction between the two deubiquitinating
enzymes OTUB1 and OTUD6B and report for the first time that both proteins
directly interact with each other
explanation: >-
Places OTUD6B within the deubiquitinase interaction network. This is
supporting context for the enzyme's role in ubiquitin signaling, not direct
evidence about the disease, hence PARTIAL.
- name: Allele-Dependent Residual OTUD6B Function
biological_scale: MOLECULAR
description: >-
The severity of the clinical phenotype tracks the predicted functional severity
of the specific OTUD6B alleles. Truncating and splice alleles that trigger
nonsense-mediated decay give little or no product, whereas some missense alleles
only locally destabilize the protein and others distort the overall fold. Molecular
dynamics modeling of two OTU-domain missense alleles predicted localized
destabilization for the allele found in a mildly affected individual and gross
fold distortion for the allele found in a severely affected individual. In one
replication family, residual wild-type splicing of under one percent, together
with alleles that spare the short OTUD6B-2 isoform, was proposed to explain an
unusually mild presentation.
downstream:
- target: Disrupted Embryonic Organogenesis and Growth
description: >-
The amount and quality of residual OTUD6B protein modulates how severely
development is perturbed, producing the observed severity gradient from severe
multisystem disease to mild intellectual disability.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: >-
our findings support that the clinical severity could be related with the
predicted functional severity of the variations in OTUD6B
explanation: >-
Ties residual protein function directly to the severity of the resulting
developmental phenotype.
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: >-
it is anticipated that Tyr216Cys in the earlier reported case with less severe
IDDFSDA will lead to localized destabilization, whereas Ile274Arg in the
presented index case with the severe IDDFSDA phenotype will lead to significant
distortion in the overall fold of OTUD6B
explanation: >-
Structural modeling and molecular dynamics link predicted protein-level damage
to observed clinical severity for two OTU-domain missense alleles.
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: >-
our findings support that the clinical severity could be related with the
predicted functional severity of the variations in OTUD6B
explanation: >-
States the genotype-severity relationship explicitly as the study's conclusion.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
we performed quantitative analysis by competitive-fluorescent RT-PCR showing
that the proband presents less than 1% of the wild-type transcript
explanation: >-
Direct patient-RNA quantification of residual normal transcript, the measurable
substrate of the residual-function idea.
- name: Impaired 26S Proteasome Assembly
biological_scale: CELLULAR
description: >-
Peripheral blood mononuclear cells from an affected individual show reduced
incorporation of 19S regulatory-particle subunits into 26S proteasomes. The
mature 26S holoenzyme is formed by capping the 20S catalytic core with the 19S
regulatory particle, so defective 19S incorporation reduces the pool of
assembly-competent, ubiquitin-receptive proteasomes.
cell_types:
- preferred_term: peripheral blood mononuclear cell
term:
id: CL:2000001
label: peripheral blood mononuclear cell
cellular_components:
- preferred_term: proteasome accessory complex (19S regulatory particle)
term:
id: GO:0022624
label: proteasome accessory complex
biological_processes:
- preferred_term: proteasome assembly
term:
id: GO:0043248
label: proteasome assembly
modifier: DECREASED
downstream:
- target: Reduced Proteasomal Chymotrypsin-Like Activity
description: >-
Fewer correctly assembled 26S proteasomes yield lower measured peptidase
activity in the same patient cells.
causal_link_type: DIRECT
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
showed reduced incorporation of 19S subunits into 26S proteasomes,
decreased chymotrypsin-like activity
explanation: >-
The same patient-cell experiment reports the assembly defect and the
peptidase-activity deficit together, supporting the direct edge between
them.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Analysis of peripheral blood mononuclear cells from an affected subject showed
reduced incorporation of 19S subunits into 26S proteasomes
explanation: >-
Direct patient-cell measurement of the proteasome-assembly defect.
- name: Reduced Proteasomal Chymotrypsin-Like Activity
biological_scale: MOLECULAR
description: >-
Chymotrypsin-like peptidase activity, the rate-limiting catalytic activity of the
20S core, is decreased in patient peripheral blood mononuclear cells, indicating
functionally reduced proteolytic throughput and not merely an assembly
stoichiometry change.
cellular_components:
- preferred_term: proteasome complex
term:
id: GO:0000502
label: proteasome complex
biological_processes:
- preferred_term: proteasome-mediated ubiquitin-dependent protein catabolic process
term:
id: GO:0043161
label: proteasome-mediated ubiquitin-dependent protein catabolic process
modifier: DECREASED
downstream:
- target: Accumulation of Ubiquitin-Protein Conjugates
description: >-
Reduced proteolytic throughput leaves polyubiquitinated substrates undegraded.
causal_link_type: DIRECT
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
decreased chymotrypsin-like activity, and accumulation of
ubiquitin-protein conjugates
explanation: >-
The reduced peptidase activity and the conjugate build-up are reported in
the same patient cells, supporting the direct degradation-failure edge.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
decreased chymotrypsin-like activity
explanation: >-
Reports the specific reduction of proteasome chymotrypsin-like peptidase
activity in cells from an affected individual.
- name: Accumulation of Ubiquitin-Protein Conjugates
biological_scale: CELLULAR
description: >-
Polyubiquitinated proteins accumulate in patient cells, the expected consequence
of a reduced-capacity ubiquitin-proteasome system. This is the proteostatic
lesion that the developing organism must tolerate.
biological_processes:
- preferred_term: ubiquitin-dependent protein catabolic process
term:
id: GO:0006511
label: ubiquitin-dependent protein catabolic process
modifier: DECREASED
downstream:
- target: Impaired Cell Growth and Proliferation
description: >-
Failure to clear ubiquitinated regulatory proteins on schedule impairs the
proliferative programs of developing tissues.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
Deubiquitinases (DUB) are increasingly linked to the regulation of
fundamental processes in normal and cancer cells, including DNA
replication and repair, programmed cell death, and oncogenes and tumor
suppressor signaling.
explanation: >-
Supports the general principle that failure of deubiquitinase-dependent
turnover perturbs replication and proliferation programs. PARTIAL because
it is a framing statement rather than a direct measurement of this edge in
OTUD6B-deficient developing tissue.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
accumulation of ubiquitin-protein conjugates
explanation: >-
Patient-cell demonstration that undegraded ubiquitin conjugates build up when
OTUD6B is lost.
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our findings suggest a role for OTUD6B in proteasome function, establish that
defective OTUD6B function underlies a multisystemic human disorder
explanation: >-
The authors' own synthesis tying the proteasome defect to the multisystem
human phenotype.
- name: Dysregulated mTORC1-Linked Translation Initiation
biological_scale: CELLULAR
description: >-
Independently of the proteasome arm, OTUD6B regulates protein synthesis
downstream of mTORC1. It associates with the protein synthesis initiation complex
and modifies components of the 48S preinitiation complex, and its two main
splicing isoforms act in opposing directions, with the long OTUD6B-1 isoform
inhibitory and the short OTUD6B-2 isoform stimulatory. This work was performed in
non-small cell lung cancer cell lines rather than in neural tissue, so its
relevance to the human developmental phenotype is inferential.
biological_processes:
- preferred_term: regulation of translation
term:
id: GO:0006417
label: regulation of translation
modifier: ABNORMAL
downstream:
- target: Impaired Cell Growth and Proliferation
description: >-
Loss of OTUD6B-dependent control over translation initiation contributes to the
growth and proliferation defect.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
These properties affect NSCLC cell proliferation, because OTUD6B-1
represses DNA synthesis while OTUD6B-2 promotes it.
explanation: >-
Explicitly connects the translation-regulatory properties of OTUD6B to
proliferation. PARTIAL because it is measured in a cancer cell line.
evidence:
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
evidence is presented that the deubiquitinase OTUD6B regulates protein
synthesis in non-small cell lung cancer (NSCLC) cells, operating downstream
from mTORC1
explanation: >-
Establishes the translation-regulatory function of OTUD6B. Marked PARTIAL
because the experiments are in a cancer cell line, not in a disease-relevant
developmental model.
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
OTUD6B associates with the protein synthesis initiation complex and modifies
components of the 48S preinitiation complex.
explanation: >-
Identifies the specific molecular target of OTUD6B in the translation
initiation machinery.
- name: Impaired Cell Growth and Proliferation
biological_scale: CELLULAR
description: >-
Both the proteostatic arm and the translational arm converge on reduced growth
and proliferative capacity. In cell models the two OTUD6B isoforms have opposing
effects on DNA synthesis, so loss of the balanced isoform pair perturbs
proliferation control rather than simply slowing it.
notes: >-
This node previously bound GO:0030182 neuron differentiation with modifier
ABNORMAL. That binding was removed: none of the node's evidence addresses
neuronal differentiation, which is instead an unsupported mechanistic claim
injected at the bridge to the neurodevelopmental output. The two processes
now bound are the ones the cited NSCLC DNA-synthesis experiments actually
speak to.
biological_processes:
- preferred_term: cell population proliferation
term:
id: GO:0008283
label: cell population proliferation
modifier: ABNORMAL
- preferred_term: growth
term:
id: GO:0040007
label: growth
modifier: DECREASED
downstream:
- target: Disrupted Embryonic Organogenesis and Growth
description: >-
A cell-autonomous proliferation deficit during embryogenesis translates into
reduced somatic growth and malformation of the organs with the highest
developmental proliferative demand.
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Homozygous Otud6b knockout mice were subviable, smaller in size, and had
congenital heart defects, consistent with the severity of loss-of-function
variants in humans.
explanation: >-
Complete loss of the gene in a mammalian model produces exactly the
reduced-growth-plus-organ-malformation output this edge asserts.
evidence:
- reference: PMID:27864334
reference_title: "Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation."
supports: PARTIAL
evidence_source: IN_VITRO
snippet: >-
These properties affect NSCLC cell proliferation, because OTUD6B-1 represses
DNA synthesis while OTUD6B-2 promotes it.
explanation: >-
Demonstrates that OTUD6B isoform balance controls proliferation. PARTIAL
because the model system is a cancer cell line.
- name: Disrupted Embryonic Organogenesis and Growth
biological_scale: ORGANISM
description: >-
The organism-level convergence node. Reduced proliferative and biosynthetic
capacity during embryogenesis produces prenatal-onset growth restriction,
microcephaly and structural brain malformation, congenital heart defects, and
the distal limb and craniofacial patterning anomalies that define the syndrome.
Homozygous Otud6b knockout mice recapitulate the severe end of this spectrum,
being subviable and small with congenital heart defects.
biological_processes:
- preferred_term: heart development
term:
id: GO:0007507
label: heart development
modifier: ABNORMAL
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Homozygous Otud6b knockout mice were subviable, smaller in size, and had
congenital heart defects, consistent with the severity of loss-of-function
variants in humans.
explanation: >-
An orthologous null mouse reproduces the growth restriction and congenital
heart disease seen at the severe end of the human spectrum, supporting a
developmental-organogenesis mechanism.
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
growth retardation with prenatal onset, feeding difficulties, structural brain
abnormalities, congenital malformations including congenital heart disease,
and musculoskeletal features
explanation: >-
The human multisystem malformation and growth phenotype that this node
represents.
phenotypes:
- name: Global Developmental Delay
description: >-
Delayed acquisition of motor, language, and adaptive milestones is present in
affected individuals and is typically the presenting concern.
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In subjects with predicted loss-of-function alleles, additional features
include global developmental delay, microcephaly, absent speech, hypotonia
explanation: >-
Lists global developmental delay among the features of individuals with
loss-of-function alleles.
- name: Intellectual Disability
description: >-
Intellectual disability is a defining feature. Severity spans the spectrum: the
most severely affected individuals lack speech and independent ambulation,
whereas individuals with alleles retaining some function can have mild
intellectual disability with normal speech and motor development.
frequency: VERY_FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0010864 Severe
intellectual disability for OMIM:617452 at 12/12 (100 percent), curated from
PMID:28343629, supporting a VERY_FREQUENT band (80-100 percent) for
intellectual disability as such. This entry deliberately binds the broader
HP:0001249 rather than the severe-ID term, because the 12/12 severity
annotation reflects the ascertainment-biased 2017 cohort and is contradicted
by later mild cases (PMID:30364145, PMID:34354232).
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
an intellectual disability syndrome associated with seizures and dysmorphic
features
explanation: >-
Intellectual disability is the anchoring feature named in the original
gene-disease report.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
At the latest neurological evaluation, at 6 years of age, she has mild
intellectual disability, mild motor difficulty, and episodic behavioral
disorders.
explanation: >-
Documents the mild end of the intellectual disability spectrum in a
replication case.
- name: Seizures
description: >-
Seizures are part of the core triad and are named in the disorder's canonical
label. Reported semiologies include generalized tonic-clonic seizures, and onset
may be in infancy or later in childhood.
frequency: VERY_FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0001250 Seizure for
OMIM:617452 at 12/12 (100 percent), curated from PMID:28343629. That maps to
the VERY_FREQUENT band (80-100 percent).
phenotype_term:
preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
an intellectual disability syndrome associated with seizures and dysmorphic
features
explanation: >-
Seizures are named as a core feature of the syndrome in the discovery cohort.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
At 5 years, tonic-clonic seizures occurred, thus valproate treatment was
started.
explanation: >-
Documents generalized tonic-clonic semiology and childhood onset in an
individual with biallelic OTUD6B splice variants.
- name: Dysmorphic Facial Features
description: >-
A recognizable dysmorphic facial gestalt accompanies the neurodevelopmental
phenotype. Reported components include long palpebral fissures and prominent,
cupped ears; the resemblance to Kabuki syndrome has led to initial misdiagnosis.
phenotype_term:
preferred_term: Abnormal facial shape
term:
id: HP:0001999
label: Abnormal facial shape
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Physical differences described for affected individuals suggest that the
disorder may be clinically recognizable, but previous publications have
reported an initial clinical suspicion for Kabuki syndrome (KS) in some
affected individuals.
explanation: >-
Establishes a recognizable dysmorphic facial phenotype and documents the
clinically important Kabuki syndrome overlap.
- name: Long Palpebral Fissures
description: >-
Horizontally elongated palpebral fissures contribute to the Kabuki-like facial
impression in affected individuals.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0000637 Long palpebral
fissure for OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629.
That maps to the FREQUENT band (30-79 percent).
phenotype_term:
preferred_term: Long palpebral fissure
term:
id: HP:0000637
label: Long palpebral fissure
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
clinical manifestations such as long palpebral fissures, prominent and cupped
ears, developmental delay, growth deficiency, persistent fetal fingertip pads,
vertebral anomaly, and seizures in the proband
explanation: >-
Names long palpebral fissures in three siblings with biallelic OTUD6B variants.
- name: Cupped Ears
description: >-
Prominent, cupped auricles are part of the reported craniofacial phenotype.
phenotype_term:
preferred_term: Cupped ear
term:
id: HP:0000378
label: Cupped ear
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
long palpebral fissures, prominent and cupped ears
explanation: >-
Directly reports prominent and cupped ears in affected siblings.
- name: Periorbital Edema
description: >-
Puffiness of the periorbital region was one of three facial features that led
the reporting authors to describe the gestalt as Williams syndrome-like and to
propose it as an expansion of the OTUD6B facial phenotype.
notes: >-
Attribution caveat. This observation comes from the single proband of
PMID:34680978, who carries both a hemizygous OTUD6B c.873delA allele in trans
with a paternally inherited 0.118 Mb 8q21.3 whole-gene deletion AND a
heterozygous ZMIZ1 splice variant, c.1491 + 2T > C, shown by mRNA study to
skip exon 14. ZMIZ1 causes its own autosomal dominant neurodevelopmental
disorder with dysmorphic facies (MONDO:0032855), which is recorded in this
entry's differential_diagnoses, so the facial gestalt in this proband cannot
be attributed to OTUD6B alone. The authors themselves only "suggest" the
expansion. Curated with supports PARTIAL for that reason. No frequency band
is given: this is a single case with no denominator.
phenotype_term:
preferred_term: Periorbital edema
term:
id: HP:0100539
label: Periorbital edema
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
We suggest that Williams syndrome-like phenotypes, namely, periorbital
edema, hanging cheek, and long and smooth philtrum represent expanded
phenotypes of OTUD6B-related ID.
explanation: >-
Author-asserted phenotypic expansion naming periorbital edema. PARTIAL
because the proband also carries a ZMIZ1 exon-14-skipping splice variant
and the authors frame the attribution as a suggestion rather than an
established finding.
- name: Hanging Cheek
description: >-
A drooping, hanging appearance of the cheeks was the second of the three
Williams syndrome-like facial features proposed as an OTUD6B phenotype
expansion.
notes: >-
Ontology gap. HPO has no term for "hanging cheek". HP:0034273 Premature
sagging cheeks is defined as sagging beyond that expected for age and
HP:0000293 Full cheeks describes increased fullness, neither of which is what
the authors describe, so this is bound to the immediate parent HP:0004426
Abnormal cheek morphology with the published wording kept in preferred_term.
Same attribution caveat as Periorbital Edema: the single PMID:34680978
proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant that
skips exon 14, and ZMIZ1-related disorder (MONDO:0032855, in this entry's
differential_diagnoses) itself causes dysmorphic facies, so attribution to
OTUD6B alone is not secure.
phenotype_term:
preferred_term: Hanging cheek
term:
id: HP:0004426
label: Abnormal cheek morphology
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
We suggest that Williams syndrome-like phenotypes, namely, periorbital
edema, hanging cheek, and long and smooth philtrum represent expanded
phenotypes of OTUD6B-related ID.
explanation: >-
Author-asserted phenotypic expansion naming hanging cheek. PARTIAL because
of the co-occurring ZMIZ1 splice variant in the same proband and the
authors' own hedged framing.
- name: Long Philtrum
description: >-
An increased distance between the nasal base and the upper lip vermilion
border was the third Williams syndrome-like facial feature proposed as an
OTUD6B phenotype expansion. It is independently annotated in phenotype.hpoa
for OMIM:617452 at 7/12 from the founding cohort, which corroborates the
feature even though this entry's snippet comes from PMID:34680978.
notes: >-
No frequency band is asserted. phenotype.hpoa does carry long philtrum at
7/12 for OMIM:617452 from PMID:28343629, which would map to FREQUENT, but the
snippet cited here is the single-proband PMID:34680978 sentence rather than
the cohort count, so the band is omitted rather than attributed to a source
this entry does not quote. Same ZMIZ1 attribution caveat as Periorbital Edema
applies to the PMID:34680978 observation itself.
phenotype_term:
preferred_term: Long philtrum
term:
id: HP:0000343
label: Long philtrum
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
We suggest that Williams syndrome-like phenotypes, namely, periorbital
edema, hanging cheek, and long and smooth philtrum represent expanded
phenotypes of OTUD6B-related ID.
explanation: >-
Author-asserted phenotypic expansion naming a long philtrum. PARTIAL
because the proband also carries a ZMIZ1 splice variant, though the
independent HPOA annotation of long philtrum at 7/12 for OMIM:617452 makes
this the best-corroborated member of the Williams-like triad.
- name: Smooth Philtrum
description: >-
Flattening of the philtral ridges accompanied the long philtrum in the same
proband and was reported as part of the Williams syndrome-like gestalt.
notes: >-
Curated separately from Long Philtrum because HPO codes philtral length
(HP:0000343) and philtral depth (HP:0000319) as distinct terms, and the
source sentence asserts both. Unlike long philtrum, smooth philtrum has no
corroborating HPOA annotation for OMIM:617452, so it rests entirely on this
one proband, who also carries the heterozygous ZMIZ1 c.1491 + 2T > C variant.
phenotype_term:
preferred_term: Smooth philtrum
term:
id: HP:0000319
label: Smooth philtrum
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
We suggest that Williams syndrome-like phenotypes, namely, periorbital
edema, hanging cheek, and long and smooth philtrum represent expanded
phenotypes of OTUD6B-related ID.
explanation: >-
Author-asserted phenotypic expansion naming a smooth philtrum. PARTIAL
because it is a single-proband observation confounded by a co-occurring
ZMIZ1 exon-14-skipping variant.
- name: Microcephaly
description: >-
Reduced occipitofrontal head circumference is reported in individuals with
predicted loss-of-function alleles, consistent with the impaired-proliferation
mechanism.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0000252 Microcephaly for
OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629. That maps to
the FREQUENT band (30-79 percent).
phenotype_term:
preferred_term: Microcephaly
term:
id: HP:0000252
label: Microcephaly
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In subjects with predicted loss-of-function alleles, additional features
include global developmental delay, microcephaly, absent speech, hypotonia
explanation: >-
Microcephaly is listed among the features of the loss-of-function subgroup.
- name: Absent Speech
description: >-
Failure to develop expressive speech occurs at the severe end of the spectrum,
in individuals with predicted loss-of-function alleles.
phenotype_term:
preferred_term: Absent speech
term:
id: HP:0001344
label: Absent speech
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
additional features include global developmental delay, microcephaly, absent
speech, hypotonia
explanation: >-
Absent speech is reported in the loss-of-function subgroup.
- name: Hypotonia
description: >-
Diminished muscle tone contributes to feeding difficulty and to delayed gross
motor milestones.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0001290 Generalized
hypotonia for OMIM:617452 at 9/12 (75 percent), curated from PMID:28343629.
That maps to the FREQUENT band (30-79 percent). The generalized term is used
here to match the HPO disease annotation.
phenotype_term:
preferred_term: Generalized hypotonia
term:
id: HP:0001290
label: Generalized hypotonia
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
global developmental delay, microcephaly, absent speech, hypotonia, growth
retardation with prenatal onset
explanation: >-
Hypotonia is listed among the features of individuals with loss-of-function
alleles.
- name: Prenatal-Onset Growth Restriction
description: >-
Growth failure begins in utero and persists postnatally, giving short stature and
low weight in addition to microcephaly.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0001511 Intrauterine
growth retardation for OMIM:617452 at 7/12 (58 percent), curated from
PMID:28343629. That maps to the FREQUENT band (30-79 percent).
phenotype_term:
preferred_term: Intrauterine growth retardation
term:
id: HP:0001511
label: Intrauterine growth retardation
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
hypotonia, growth retardation with prenatal onset, feeding difficulties
explanation: >-
Explicitly reports growth retardation with prenatal onset.
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
developmental delay, growth deficiency, persistent fetal fingertip pads
explanation: >-
Independent confirmation of growth deficiency in a second family.
- name: Feeding Difficulties
description: >-
Poor feeding is common and, at the severe end of the spectrum, can require
gastrostomy or other enteral feeding support.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0011968 Feeding
difficulties for OMIM:617452 at 9/12 (75 percent), curated from
PMID:28343629. That maps to the FREQUENT band (30-79 percent).
phenotype_term:
preferred_term: Feeding difficulties
term:
id: HP:0011968
label: Feeding difficulties
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
growth retardation with prenatal onset, feeding difficulties, structural brain
abnormalities
explanation: >-
Feeding difficulties are reported in the loss-of-function subgroup.
- name: Structural Brain Abnormalities
description: >-
Nonspecific structural brain abnormalities are seen on neuroimaging in a subset
of affected individuals, with inter- and intrafamilial variability in the imaging
findings.
phenotype_term:
preferred_term: Abnormal brain morphology
term:
id: HP:0012443
label: Abnormal brain morphology
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
feeding difficulties, structural brain abnormalities, congenital malformations
including congenital heart disease
explanation: >-
Reports structural brain abnormalities as part of the multisystem phenotype.
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
our patients showed inter- and intrafamilial differences with regard to the
clinical and brain imaging findings
explanation: >-
Documents variability of the brain imaging phenotype within and between
OTUD6B families.
- name: Congenital Heart Disease
description: >-
Congenital cardiac malformations occur in a subset of affected individuals and
are recapitulated in the Otud6b null mouse, making cardiac evaluation part of
initial assessment. Septal defects predominate, but conotruncal malformation
also occurs: one proband was ascertained through antenatal diagnosis of
Tetralogy of Fallot, and a preceding pregnancy in the same family was
terminated for the same finding.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates the specific cardiac lesions
for OMIM:617452 against a cardiac-evaluated denominator of 6, giving atrial
septal defect 3/6 (50 percent) and ventricular septal defect 2/6 (33
percent), both curated from PMID:28343629. Either maps to the FREQUENT band
(30-79 percent), so FREQUENT is applied to the parent cardiac term. Note the
denominator is 6, not the 12 used for the neurological terms, because only a
subset of the founding cohort had cardiac assessment reported.
phenotype_term:
preferred_term: Abnormal heart morphology
term:
id: HP:0001627
label: Abnormal heart morphology
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
congenital malformations including congenital heart disease, and
musculoskeletal features
explanation: >-
Reports congenital heart disease among the malformations in affected humans.
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Homozygous Otud6b knockout mice were subviable, smaller in size, and had
congenital heart defects
explanation: >-
The orthologous null mouse independently supports a causal role for OTUD6B loss
in congenital heart defects.
- reference: PMID:35707595
reference_title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we report one additional case with Tetralogy of Fallot (ToF), who has
microcephaly and dysmorphic features along with renal parenchymal disease
with simple cortical cysts
explanation: >-
Extends the cardiac phenotype beyond septal defects to a conotruncal
malformation in a genetically confirmed individual. The renal cystic disease
in the same proband is attributed by the authors to a separate PKD1 variant
and is therefore not curated as an OTUD6B feature here.
- name: Persistent Fetal Fingertip Pads
description: >-
Persistence of the fetal fingertip pads is one of the recognizable distal limb
findings and, together with broad distal phalanges and prominent interphalangeal
joints, has been proposed as a diagnostic handle.
phenotype_term:
preferred_term: Prominent fingertip pads
term:
id: HP:0001212
label: Prominent fingertip pads
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
growth deficiency, persistent fetal fingertip pads, vertebral anomaly, and
seizures in the proband
explanation: >-
Directly reports persistent fetal fingertip pads in affected siblings.
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Broad distal phalanges (especially the thumbs and halluces) with prominent
interphalangeal joints and fetal pads were recognized in all patients and
hence considered pathognomonic.
explanation: >-
Independent report of fetal pads in all five patients of two Egyptian families.
- name: Broad Distal Phalanges
description: >-
Broadening of the distal phalanges, most conspicuous in the thumbs and halluces,
is one of the distal limb anomalies named in the disorder's canonical label. In
one series this finding was present in all five affected individuals and was
considered pathognomonic by the authors.
frequency: FREQUENT
notes: >-
Frequency derivation: phenotype.hpoa annotates HP:0011304 Broad thumb for
OMIM:617452 at 6/12 (50 percent), curated from PMID:28343629. That maps to
the FREQUENT band (30-79 percent). The HPO disease annotation uses the thumb
term, which is also the digit the primary reports single out, so that term is
bound here; the halluces are affected in parallel but are not separately
annotated in HPOA.
phenotype_term:
preferred_term: Broad distal phalanges of the thumbs and halluces
term:
id: HP:0011304
label: Broad thumb
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Broad distal phalanges (especially the thumbs and halluces) with prominent
interphalangeal joints and fetal pads were recognized in all patients and
hence considered pathognomonic.
explanation: >-
Reports broad distal phalanges of thumbs and halluces in all patients studied.
- name: Prominent Interphalangeal Joints
description: >-
Prominence of the interphalangeal joints accompanies the broad distal phalanges
in the characteristic hand and foot phenotype.
phenotype_term:
preferred_term: Prominent interphalangeal joints
term:
id: HP:0006237
label: Prominent interphalangeal joints
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Broad distal phalanges (especially the thumbs and halluces) with prominent
interphalangeal joints and fetal pads
explanation: >-
Directly reports prominent interphalangeal joints as part of the distal limb
phenotype.
- name: Polydactyly
description: >-
Supernumerary digits were reported in one affected girl alongside terminal
broadening of the fingers, extending the distal limb phenotype beyond
broadening and joint prominence. This is a single-case observation and is not
part of the HPO disease annotation for OMIM:617452.
phenotype_term:
preferred_term: Polydactyly
term:
id: HP:0010442
label: Polydactyly
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
The patient also had terminal broadening of the fingers and polydactyly.
explanation: >-
Reports polydactyly with terminal digital broadening. Marked PARTIAL because
this proband also carries a heterozygous ZMIZ1 c.1491 + 2T > C splice variant
that skips exon 14, so attribution of the limb finding to OTUD6B alone is not
secure. See the ZMIZ1 entry (MONDO:0032855) in differential_diagnoses.
- name: Macrodontia
description: >-
Abnormally large teeth are part of a distinctive orodental phenotype that also
includes dental crowding, abnormally shaped teeth, and thick alveolar ridges.
phenotype_term:
preferred_term: Macrodontia
term:
id: HP:0001572
label: Macrodontia
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
various orodental features were present including macrodontia, dental
crowding, abnormally shaped teeth, and thick alveolar ridges
explanation: >-
Directly reports macrodontia in the Egyptian OTUD6B cohort.
- name: Dental Crowding
description: >-
Crowding of the dental arch accompanies macrodontia in the orodental phenotype.
phenotype_term:
preferred_term: Dental crowding
term:
id: HP:0000678
label: Dental crowding
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
including macrodontia, dental crowding, abnormally shaped teeth, and thick
alveolar ridges
explanation: >-
Directly reports dental crowding.
- name: Abnormally Shaped Teeth
description: >-
Abnormal crown morphology is reported alongside macrodontia and crowding.
phenotype_term:
preferred_term: Abnormal dental morphology
term:
id: HP:0006482
label: Abnormal dental morphology
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar
ridges
explanation: >-
Directly reports abnormally shaped teeth.
- name: Delayed Eruption of Primary Teeth
description: >-
Delayed eruption of the primary dentition was reported as a novel feature in a
three-sibling family, extending the orodental phenotype.
phenotype_term:
preferred_term: Delayed eruption of primary teeth
term:
id: HP:0000680
label: Delayed eruption of primary teeth
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
previously unreported clinical manifestations such as delayed eruption of
primary dentition, soft doughy skin with reduced sweating, and mirror movements
present in our patients suggest an expansion of the phenotype
explanation: >-
Reports delayed eruption of primary dentition as a phenotype-expanding finding.
- name: Vertebral Anomalies
description: >-
Vertebral segmentation or morphology anomalies are reported among the
musculoskeletal features.
phenotype_term:
preferred_term: Abnormal vertebral morphology
term:
id: HP:0003468
label: Abnormal vertebral morphology
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
persistent fetal fingertip pads, vertebral anomaly, and seizures in the proband
explanation: >-
Reports a vertebral anomaly in the proband of the three-sibling family.
- name: Mirror Movements
description: >-
Involuntary mirrored movements of the contralateral hand were reported as a novel
neurological finding, suggesting abnormal development or decussation of
corticospinal projections.
phenotype_term:
preferred_term: Mirror movements
term:
id: HP:0001335
label: Bimanual synkinesia
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
delayed eruption of primary dentition, soft doughy skin with reduced sweating,
and mirror movements present in our patients suggest an expansion of the
phenotype
explanation: >-
Reports mirror movements as a newly described feature in OTUD6B-related disease.
- name: Soft Doughy Skin
description: >-
Soft, doughy skin texture was described as part of the phenotype expansion in a
three-sibling family.
phenotype_term:
preferred_term: Soft skin
term:
id: HP:0000977
label: Soft skin
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
soft doughy skin with reduced sweating
explanation: >-
Directly reports soft doughy skin.
- name: Reduced Sweating
description: >-
Reduced sweating was reported together with the soft doughy skin texture,
suggesting an ectodermal component to the phenotype.
phenotype_term:
preferred_term: Hypohidrosis
term:
id: HP:0000966
label: Hypohidrosis
evidence:
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
soft doughy skin with reduced sweating, and mirror movements
explanation: >-
Directly reports reduced sweating.
- name: Hypothyroidism
description: >-
Hypothyroidism has been reported in multiple unrelated affected individuals and
is a treatable comorbidity, making thyroid function testing worthwhile at
diagnosis.
phenotype_term:
preferred_term: Hypothyroidism
term:
id: HP:0000821
label: Hypothyroidism
evidence:
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
this is the third patient with associated hypothyroidism and
hypogammaglobulinemia, underscoring the value of screening for these
conditions in other patients
explanation: >-
Identifies hypothyroidism recurring across at least three unrelated affected
individuals.
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A 6-month-old girl presented with nystagmus and hypothyroidism.
explanation: >-
A further independent case of hypothyroidism in a genetically confirmed
individual.
- name: Hypogammaglobulinemia
description: >-
Reduced circulating immunoglobulin has been reported alongside hypothyroidism in
a minority of affected individuals, prompting recommendations for immunologic
screening.
phenotype_term:
preferred_term: Hypogammaglobulinemia
term:
id: HP:0004313
label: Decreased circulating immunoglobulin concentration
evidence:
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
the third patient with associated hypothyroidism and hypogammaglobulinemia
explanation: >-
Reports hypogammaglobulinemia recurring in a third unrelated affected
individual.
- name: Nystagmus
description: >-
Nystagmus was the presenting sign in a 6-month-old girl who also had optic disc
hypoplasia and retinal abnormalities.
phenotype_term:
preferred_term: Nystagmus
term:
id: HP:0000639
label: Nystagmus
evidence:
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A 6-month-old girl presented with nystagmus and hypothyroidism.
explanation: >-
Reports nystagmus as the presenting ocular sign in a genetically confirmed case.
- name: Optic Disc Hypoplasia and Ocular Developmental Anomalies
description: >-
Optic disc hypoplasia with retinal abnormalities was described in a single
reported individual. The authors emphasize that this was the first such report
and call for further investigation before accepting ocular developmental anomaly
as an established part of the phenotype.
frequency: VERY_RARE
notes: >-
Frequency derivation: PMID:41188742 states that none of the 27 previously
reported IDDFSDA cases exhibited ocular developmental abnormalities, and reports
one new case with them. That gives 1 of 28 reported individuals (approximately
3.6 percent), which maps to the VERY_RARE band (1-4 percent). This is the only
phenotype in this entry with a published denominator; all others omit a
frequency band deliberately.
phenotype_term:
preferred_term: Optic disc hypoplasia
term:
id: HP:0007766
label: Optic disc hypoplasia
evidence:
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
On admission, optic disc hypoplasia and retinal abnormalities were detected
with a typical phenotype of IDDFSDA.
explanation: >-
Reports optic disc hypoplasia and retinal abnormalities in a genetically
confirmed individual.
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
Significantly, none of the 27 previously reported IDDFSDA cases exhibited
ocular developmental abnormalities.
explanation: >-
Supplies the denominator for the VERY_RARE band and simultaneously flags that
the association rests on a single observation.
- name: Retinal Degeneration
description: >-
Retinal degeneration was initially observed in two brothers with homozygous
OTUD6B variants, but exome reanalysis showed it was caused by a co-segregating
homozygous RP1L1 nonsense variant causing autosomal recessive retinitis
pigmentosa 88, not by OTUD6B. This entry records retinal degeneration as
explicitly excluded from the OTUD6B phenotype. It is distinct from the optic
disc hypoplasia and retinal abnormalities reported separately in PMID:41188742,
which remain a single unreplicated observation.
phenotype_term:
preferred_term: Retinal degeneration
term:
id: HP:0000546
label: Retinal degeneration
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
Retinal degeneration, albeit present in both patients from Family I, was shown
to be unrelated to OTUD6B, demonstrating the need for in-depth analysis of WES
data in consanguineous families to uncover simultaneous autosomal recessive
disorders.
explanation: >-
Explicitly refutes retinal degeneration as part of the OTUD6B phenotype and
attributes it to a second, independent recessive disorder in the same family.
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
Biallelic pathogenic variants in RP1L1 cause autosomal recessive retinitis
pigmentosa type 88 (RP88). Thus, RP1L1 dysfunction likely accounts for the
visual phenotype in this family
explanation: >-
Names the alternative causal gene, closing the loop on the exclusion.
genetic:
- name: OTUD6B biallelic pathogenic variants
gene_term:
preferred_term: OTUD6B
term:
id: hgnc:24281
label: OTUD6B
association: Biallelic pathogenic variants are causative for IDDFSDA
relationship_type: CAUSATIVE
variant_origin: GERMLINE
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:35430327
reference_title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
an autosomal recessive multisystem disorder caused by compound heterozygous
or homozygous variants in the gene OTUD6B
explanation: >-
States the recessive, biallelic disease model for OTUD6B.
notes: >-
Reported disease alleles span several classes. Nonsense: c.271C>T p.(Gln91Ter)
(Egyptian family) and c.433C>T p.(Arg145*) (Mexican case). Canonical splice
donor: c.324+1G>C and c.405+1G>A (Italian replication case), functionally shown
to cause exon 2 and exon 3 skipping with nonsense-mediated decay. Missense in the
OTU domain: c.767G>T p.(Gly256Val), c.815T>G p.(Ile272Arg), plus Tyr216Cys and
Ile274Arg analyzed by molecular dynamics. Compound heterozygous
frameshift-plus-missense genotypes have also been reported, and in one proband
the second hit was a 0.118 Mb paternally inherited 8q21.3 deletion spanning
OTUD6B in trans with a maternal frameshift, so chromosomal microarray as well as
sequencing can be needed to establish biallelic status. Reported missense alleles
cluster in or immediately adjacent to the OTU catalytic domain. Transcript
numbering follows NM_016023.5 and the 293-residue UniProt Q8N6M0 protein; note
that the original 2017 paper's full text uses a longer isoform numbering, so
residue positions quoted across papers are not directly comparable without
checking the isoform. ClinGen classifies the OTUD6B-syndromic intellectual
disability relationship as Definitive (AR, SOP10, Intellectual Disability and
Autism Gene Curation Expert Panel, 2024-08-22); that structured assertion could
not be cached as a CGGV reference here (see the entry-level notes), so it is
recorded descriptively rather than as a validated snippet.
evidence:
- reference: PMID:28343629
reference_title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6
independent families with an intellectual disability syndrome associated with
seizures and dysmorphic features
explanation: >-
The gene-disease-establishing multi-family cohort.
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Whole-exome sequencing (WES) identified a novel nonsense variant in OTUD6B
(c.271C>T, p.(Gln91Ter))
explanation: >-
Documents a specific nonsense allele identified by exome sequencing.
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In Family II, targeted sequencing revealed a novel homozygous missense variant
(c.767G>T, p.(Gly256Val)), confirming the clinically suspected OTUD6B-related ID.
explanation: >-
Documents a homozygous OTU-domain missense allele.
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The homozygous c.433C>T (p.Arg145*) variant of the OTUD6B gene confirmed this
intellectual disability syndrome.
explanation: >-
Documents a homozygous nonsense allele in an independent case.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
both variants affect OTUD6B splicing and lead to the production of aberrant
transcripts
explanation: >-
Patient-RNA functional validation that the two canonical splice-donor alleles
are indeed loss-of-function.
- reference: PMID:35707595
reference_title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
was revealed by whole exome sequencing (WES) along with a previously
reported heterozygous PKD1 variant, unraveling the blended phenotype
observed in the proband.
explanation: >-
Documents a further homozygous OTU-domain missense allele, c.815T>G
p.(Ile272Arg), and is an explicit
worked example of a blended two-locus phenotype, which matters for attribution
discipline in this disorder.
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3,
chr8:92084087-92202189, with OTUD6B involved.
explanation: >-
Documents the allelic class of a whole-gene copy-number deletion supplying
the second hit in trans with a point mutation. The diagnostic-workup
consequence of this allelic class is modeled in the diagnosis section
rather than here.
diagnosis:
- name: Trio Exome Sequencing
description: >-
There are no formal clinical diagnostic criteria; the diagnosis is molecular.
Trio-based exome sequencing is the appropriate first-line test for a child
with global developmental delay, seizures, the distal limb findings, and a
dysmorphic facial gestalt, and it is how the reported cases were ascertained.
The trio design matters specifically because the disorder is autosomal
recessive: phasing the two candidate alleles across the parents is what
establishes that they are in trans, and it is also what identifies each
parent as a carrier for counseling.
diagnosis_term:
preferred_term: trio exome sequencing
term:
id: NCIT:C101295
label: Whole Exome Sequencing
results: >-
Biallelic OTUD6B variants in trans; reported alleles include splice-donor,
frameshift, nonsense, and OTU-domain missense changes
markers: OTUD6B (hgnc:24281)
evidence:
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pathogenic gene variants were identified using whole exome trio sequencing
(trioWES) and confirmed using Sanger sequencing.
explanation: >-
States the trio exome plus Sanger confirmation pathway that produced the
molecular diagnosis in a genetically confirmed case.
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Sanger sequencing confirmed the segregation of the variants in the family,
showing that both parents are carriers of one mutation.
explanation: >-
Documents the parental segregation step that establishes the two alleles
are in trans, which is the reason the trio design is specified here.
- name: Chromosomal Microarray
description: >-
Chromosomal microarray is required alongside sequencing rather than being
superseded by it. One reported proband is a compound heterozygote for an
OTUD6B point mutation and a paternally inherited 0.118 Mb whole-gene deletion
of 8q21.3; exome sequencing alone reports that individual as a single
heterozygote and the diagnosis is missed. A single apparently heterozygous
OTUD6B variant in a clinically compatible child should therefore prompt
copy-number analysis of the locus.
diagnosis_term:
preferred_term: chromosomal microarray testing
term:
id: NCIT:C18477
label: Microarray Analysis
results: >-
May reveal a whole-gene or partial-gene 8q21.3 deletion supplying the second
hit in trans with a sequence variant
markers: 8q21.3
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Cytogenomic microarray (CMA), whole exome sequencing (WES), and mRNA
analysis were performed.
explanation: >-
Records the combined assay panel used to reach this diagnosis, with CMA run
in parallel with sequencing rather than as a superseded first-tier test.
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The CMA showed a paternally inherited 0.118 Mb deletion of 8q21.3,
chr8:92084087-92202189, with OTUD6B involved.
explanation: >-
The specific copy-number second hit that only microarray detected, which is
what makes CMA non-optional in this disorder's workup.
- name: Reflex OTUD6B Testing in Suspected Rubinstein-Taybi or Kabuki Syndrome
description: >-
The facial gestalt overlaps two better-known syndromes, so affected children
are commonly worked up for those first. The authors of the first replication
report explicitly recommend screening OTUD6B in a child suspected of having
Rubinstein-Taybi syndrome once CREBBP and EP300 are negative. An initial
clinical suspicion of Kabuki syndrome has likewise been recorded in several
affected individuals. This is actionable reflex testing rather than an
academic differential.
diagnosis_term:
preferred_term: reflex OTUD6B genetic testing
term:
id: NCIT:C15709
label: Genetic Testing
results: >-
Biallelic OTUD6B variants in a child previously worked up, negatively, for
Rubinstein-Taybi or Kabuki syndrome
evidence:
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
appropriateness of screening OTUD6B in suspected Rubinstein-Taybi syndrome
patients with negative results after the screening of the major genes
explanation: >-
The authors' own explicit reflex-testing recommendation, which is a
diagnostic-pathway claim rather than a phenotype claim.
- reference: PMID:38389298
reference_title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
previous publications have reported an initial clinical suspicion for
Kabuki syndrome (KS) in some affected individuals
explanation: >-
Documents that the Kabuki misdirection has actually occurred in practice,
supporting the second half of the reflex-testing recommendation.
treatments:
- name: Antiseizure Pharmacotherapy
description: >-
Seizures are managed with standard antiseizure medication. Valproate was used to
treat generalized tonic-clonic seizures in a reported individual with biallelic
OTUD6B splice variants. There is no disorder-specific antiseizure protocol and no
evidence that any particular agent is preferred in OTUD6B-related disease; drug
choice follows general pediatric epilepsy practice and seizure semiology.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: valproic acid
term:
id: CHEBI:39867
label: valproic acid
evidence:
- reference: PMID:30364145
reference_title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
At 5 years, tonic-clonic seizures occurred, thus valproate treatment was
started.
explanation: >-
Documents actual antiseizure pharmacotherapy in a genetically confirmed
individual.
- name: Levothyroxine Replacement for Hypothyroidism
description: >-
Hypothyroidism recurs in unrelated affected individuals and is the one
genuinely treatable manifestation of this disorder, which is why endocrine
surveillance is recommended in the first place. Standard thyroid hormone
replacement is used; nothing about the OTUD6B genotype changes the drug or
the monitoring. In the reported Chinese case, levothyroxine was started in
the week the newborn metabolic screen returned, and by 3 years 6 months the
dose had been titrated down with thyroid function in the normal range on
every check, so this is a treatment with a documented biochemical response
in a genetically confirmed individual.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: levothyroxine
term:
id: CHEBI:18332
label: L-thyroxine
evidence:
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
She started levothyroxine sodium tablets that same week.
explanation: >-
Documents actual levothyroxine therapy in a genetically confirmed
individual with OTUD6B-related hypothyroidism.
- reference: PMID:41188742
reference_title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
At her last visit, age 3 years 6 months, the dose was down
to 12.5 µg daily, with every thyroid check since 3monts
age within the normal range.
explanation: >-
Records the biochemical response and dose titration on follow-up. Quoted
verbatim from the cached full text including its typographic artifacts
("3monts"), per the never-retype rule.
- name: Endocrine and Immunologic Surveillance
description: >-
Because hypothyroidism and hypogammaglobulinemia have recurred in unrelated
affected individuals and both are treatable, thyroid function testing and
immunoglobulin quantification are recommended at diagnosis and on follow-up.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
evidence:
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
the third patient with associated hypothyroidism and hypogammaglobulinemia,
underscoring the value of screening for these conditions in other patients
explanation: >-
The authors explicitly recommend screening for these two treatable
comorbidities in other affected individuals.
- name: Multidisciplinary Supportive Care
description: >-
Management is supportive and symptom-directed: seizure control, nutritional and
feeding support for poor growth and feeding difficulty, developmental and
rehabilitative therapies, cardiac evaluation for congenital heart disease, and
dental care for the orodental phenotype. There is no disease-modifying therapy.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
evidence:
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The current challenge with this patient is to ensure medical management of his
seizures and provide him with a better quality of life.
explanation: >-
Characterizes present-day management as symptomatic and quality-of-life
focused rather than disease-modifying.
- reference: PMID:32924626
reference_title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
The possibilities of additional therapeutic approaches may increase by
understanding the physiopathology of the involved pathways.
explanation: >-
States that mechanism-targeted therapy does not yet exist and remains
aspirational.
- name: Genetic Counseling and Carrier Testing
description: >-
Autosomal recessive inheritance gives a 25 percent sibling recurrence risk.
Counseling should cover the recessive model, carrier testing of parents and
at-risk relatives, and the option of prenatal or preimplantation testing once the
familial variants are known. Consanguinity is common in reported families, and
the RP1L1 experience in PMID:34354232 shows that a second independent recessive
disorder can co-segregate and confound the phenotype, so exome or genome data
should be reanalyzed in depth in consanguineous pedigrees.
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:34354232
reference_title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
demonstrating the need for in-depth analysis of WES data in consanguineous
families to uncover simultaneous autosomal recessive disorders
explanation: >-
Directly supports the counseling and reanalysis recommendation for
consanguineous families.
differential_diagnoses:
- name: BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
disease_term:
preferred_term: BPTF-related neurodevelopmental disorder (NEDDFL)
term:
id: MONDO:0060596
label: neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
description: >-
A distinct autosomal dominant entity (MONDO:0060596, OMIM:617755) caused by
heterozygous variants in BPTF (hgnc:3581). Its MONDO label differs from this
disorder's by two words, which makes it the single most likely entity to be
conflated with OTUD6B disease in a text or label-based search.
distinguishing_features:
- >-
Molecular: BPTF (hgnc:3581) heterozygous, autosomal dominant and typically de
novo, versus OTUD6B (hgnc:24281) biallelic and autosomal recessive. The
inheritance mode alone separates them in almost every family.
- >-
Nomenclature: the near-identical MONDO labels are the hazard, not the
phenotypes. Confirm the causative gene before importing any cohort data
published under the "dysmorphic facies and distal limb anomalies" phrasing.
notes: >-
PMID:33522091 is cited here, and only here. It is a 25-individual NEDDFL
cohort and it is exactly the kind of paper a label-based search would sweep
into this entry by mistake; recording it against the differential is the
honest place for it, and none of its phenotype data is used anywhere in the
OTUD6B sections.
evidence:
- reference: PMID:33522091
reference_title: "Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neurodevelopmental disorder with dysmorphic facies and distal limb
anomalies (NEDDFL), defined primarily by developmental delay/intellectual
disability, speech delay, postnatal microcephaly, and dysmorphic features,
is a syndrome resulting from heterozygous variants in the dosage-sensitive
bromodomain PHD finger chromatin remodeler transcription factor BPTF gene.
explanation: >-
Establishes in the source's own words that the near-identically labelled
NEDDFL entity is caused by heterozygous BPTF variants, which is the
molecular discriminator this differential turns on.
- name: ZMIZ1-related neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies
disease_term:
preferred_term: ZMIZ1-related neurodevelopmental disorder (NEDDFSA)
term:
id: MONDO:0032855
label: neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies
description: >-
A distinct autosomal dominant entity (MONDO:0032855, OMIM:618659) caused by
heterozygous variants in ZMIZ1 (hgnc:16493). Its label differs from this
disorder's only in "skeletal" versus "limb". This is not only a label
hazard: PMID:34680978 reports a proband who genuinely carries variants in
both genes, so the two entities can co-occur in one patient.
distinguishing_features:
- >-
Molecular: ZMIZ1 (hgnc:16493) heterozygous and autosomal dominant, versus
biallelic recessive OTUD6B. ZMIZ1 is a transcriptional coregulator, not a
deubiquitinase, so there is no shared mechanism to justify pooling evidence.
- >-
Co-occurrence, not just confusion: in PMID:34680978 the same 5-year-old girl
carries a hemizygous OTUD6B c.873delA over a paternal 8q21.3 whole-gene
deletion AND a heterozygous ZMIZ1 c.1491 + 2T > C splice variant confirmed by
mRNA study to skip exon 14. Her Williams syndrome-like facial features
(periorbital edema, hanging cheek, long and smooth philtrum) and her
polydactyly are curated in this entry with supports PARTIAL for exactly this
reason. Finding a ZMIZ1 variant therefore does not exclude OTUD6B disease,
and vice versa.
notes: >-
Cross-reference: the phenotypes Periorbital Edema, Hanging Cheek, Long
Philtrum, Smooth Philtrum, and Polydactyly in this entry all derive from the
dual-locus PMID:34680978 proband and all name this differential in their
attribution notes.
evidence:
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The OTUD6B and ZMIZ1 genes were recently identified as causes of syndromic
intellectual disability (ID) with shared phenotypes of facial dysmorphism,
distal limb anomalies, and seizure disorders.
explanation: >-
States the phenotypic overlap that makes ZMIZ1 a differential for this
disorder, in the authors' own words.
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
OTUD6B- and ZMIZ1-related ID are inherited in autosomal recessive and
autosomal dominant patterns, respectively.
explanation: >-
Sources the inheritance-mode discriminator that separates the two entities
in nearly every family.
- reference: PMID:34680978
reference_title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This ZMIZ1 variant yielded exon 14 skipping, as evidenced by mRNA study.
explanation: >-
Functional confirmation that the second-locus ZMIZ1 allele in this proband
is real and consequential, which is what makes it a genuine confounder for
the facial phenotypes rather than an incidental finding.
- name: OTUD5-related multiple congenital anomalies syndrome
disease_term:
preferred_term: OTUD5-related multiple congenital anomalies-neurodevelopmental syndrome (MCAND)
term:
id: MONDO:0025351
label: multiple congenital anomalies-neurodevelopmental syndrome, X-linked
description: >-
An X-linked disorder (MONDO:0025351, OMIM:301056) caused by hemizygous
variants in OTUD5 (hgnc:25402), confirmed against the MONDO
`RO:0004003` gene-association relation. OTUD5 is a member
of the same OTU deubiquitinase family as OTUD6B, so the two share
ubiquitin-signalling mechanism language and are frequently co-discussed in
reviews of OTU-family disease.
distinguishing_features:
- >-
Molecular: X-linked hemizygous OTUD5 in males, versus autosomal recessive
biallelic OTUD6B in either sex.
- >-
Literature hazard: papers about "OTU deubiquitinase deficiency" may describe
either gene. Check which gene the reported cohort actually carries variants
in before citing it here.
- name: OTUD7A-related phenotypes and the 15q13.3 microdeletion syndrome
disease_term:
preferred_term: 15q13.3 microdeletion syndrome (the OTUD7A-containing interval)
term:
id: MONDO:0012774
label: chromosome 15q13.3 microdeletion syndrome
notes: >-
The bound term is the contiguous-gene deletion syndrome (MONDO:0012774,
OMIM:612001), not an OTUD7A gene-disease entity. MONDO carries no
`RO:0004003` OTUD7A association on this term, and there is no separate clean
MONDO entity for OTUD7A-related disease, so the deletion syndrome is the
correct and only bindable target. The OTUD7A framing is retained in the
description because the literature hazard is the gene-family adjacency, not
the deletion syndrome's clinical picture.
description: >-
OTUD7A lies within the 15q13.3 microdeletion critical region and is another
OTU-family gene implicated in neurodevelopmental disease, so it appears
alongside OTUD6B in family-level reviews.
distinguishing_features:
- >-
Molecular: a recurrent copy-number loss at 15q13.3 detected by
chromosomal microarray, versus biallelic OTUD6B sequence variants detected
by exome or gene-panel sequencing. Different assay, different mechanism.
references:
- reference: PMID:28343629
title: "Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features."
- reference: PMID:30364145
title: "First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features."
- reference: PMID:31147255
title: "[First Spanish case of syndromic intellectual disability with dysmorphic facies, seizures, and distal limb anomalies caused by balletic mutations in the OTUD6B gene]."
- reference: PMID:32181568
title: Phenotypic expansion of OTUD6B-related syndrome.
- reference: PMID:32924626
title: "Comparison of Genetic Variants and Manifestations of OTUD6B-Related Disorder: The First Mexican Case."
- reference: PMID:34354232
title: "OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype."
- reference: PMID:34680978
title: "Compound Heterozygote of Point Mutation and Chromosomal Microdeletion Involving OTUD6B Coinciding with ZMIZ1 Variant in Syndromic Intellectual Disability."
- reference: PMID:35707595
title: "A New Family with a Novel OTUD6B Mutation: Practicing Whole Exome Sequencing for Antenatal Diagnosis of Tetralogy of Fallot."
- reference: PMID:35430327
title: "Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations."
- reference: PMID:38389298
title: "Biallelic OTUD6B variants associated with a Kabuki syndrome-like disorder in three siblings: A clinical report and literature review."
- reference: PMID:41188742
title: "Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case."
- reference: PMID:27864334
title: Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation.
- reference: PMID:33421002
title: Studying OTUD6B-OTUB1 Protein-Protein Interaction by Low-Throughput GFP-Trap Assays and High-Throughput AlphaScreen Assays.
- reference: PMID:33522091
title: "Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies."
Prepared: 2026‑08‑01 · Target entity: OTUD6B‑Related Neurodevelopmental Disorder · MONDO:0044319
Three disambiguation hazards apply to this entity and should be treated as Named Entity Confusion (NEC) risk per the dismech DR SOP:
OTUD6B-AS1 is a different molecular entity. Of ~76 PubMed records for "OTUD6B," the large majority (≈40) concern OTUD6B‑AS1, a long non‑coding antisense RNA transcribed at the same 8q21.3 locus, studied almost exclusively as a cancer biomarker (breast, colorectal, cervical, thyroid, bladder). None of these bear on the neurodevelopmental disorder. Do not cite OTUD6B‑AS1 papers as OTUD6B evidence.OTUD7A is a different DUB / different NDD gene. OTUD7A (15q13.3 microdeletion driver, MIM 612024) also causes a DUB‑related NDD with epilepsy and ID (PMID:36604605). It is a sister-gene confusion, not the same disease.OTUD6A is a paralog at Xq26.1, not currently a Mendelian disease gene.MONDO identity anchors verified: MONDO:0044319 carries xrefs OMIM:617452, Orphanet:505237, GARD:0017942, MEDGEN:1375601, UMLS:C4479520, and sits under MONDO:0000508 (syndromic intellectual disability) — matching the ClinGen gene‑disease validity assertion (below). Causal gene = OTUD6B. Preflight passes.
Protein numbering discrepancy to resolve before curating catalytic residues: UniProt canonical Q8N6M0 is a 293‑aa protein with the OTU domain at residues 147–284 and catalytic residues Cys158 (nucleophile) / His277. The original AJHG paper's full text (per PMC5384096) describes a 323‑aa protein with a predicted active site of "Asp185, Cys188, and His307" — an offset consistent with a longer alternative isoform's numbering. All clinically reported variants use NM_016023.5 / 293‑aa numbering (e.g., p.Lys291AsnfsTer3 is near the C‑terminus of a 293‑aa protein). Anchor on the 293‑aa numbering; flag the 323‑aa figures as isoform‑dependent.
Verbatim status of quotations below: Abstract text marked with > block quotes was retrieved verbatim from PubMed record pages and is suitable for evidence snippet: use after just fetch-reference + just validate-references. Figures attributed to PMC5384096 full text were extracted by an automated reader and are paraphrase-risk — verify against the article before using as snippets.
OTUD6B‑related neurodevelopmental disorder is a rare autosomal recessive multisystem developmental disorder caused by biallelic loss‑of‑function variants in OTUD6B, which encodes an ovarian‑tumour (OTU)‑domain deubiquitinating enzyme. The core phenotype is global developmental delay and intellectual disability with early‑onset seizures, a recognizable dysmorphic facial gestalt, and distal limb anomalies (notably broad distal phalanges/thumbs with persistent fetal fingertip pads). Prenatal‑onset growth restriction, microcephaly, hypotonia, feeding difficulty, structural brain anomalies, and congenital heart disease are frequent. Severity is strikingly bimodal: predicted‑null biallelic genotypes produce a severe, often non‑ambulatory, non‑verbal, gastrostomy‑dependent phenotype, whereas hypomorphic missense/leaky‑splice genotypes may produce only mild‑to‑moderate ID with preserved speech and ambulation.
The disorder was defined in 2017 by Santiago‑Sim et al. in the American Journal of Human Genetics (PMID:28343629), with 12 individuals from 6 families:
Ubiquitination is a posttranslational modification that regulates many cellular processes including protein degradation, intracellular trafficking, cell signaling, and protein-protein interactions. Deubiquitinating enzymes (DUBs), which reverse the process of ubiquitination, are important regulators of the ubiquitin system. OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features. In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans. Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates. Our findings suggest a role for OTUD6B in proteasome function, establish that defective OTUD6B function underlies a multisystemic human disorder, and provide additional evidence for the emerging relationship between the ubiquitin system and human disease. — Santiago‑Sim T et al., Am J Hum Genet 2017;100(4):676‑688. doi:10.1016/j.ajhg.2017.03.001 (PMID:28343629)
| Resource | Identifier | Label |
|---|---|---|
| MONDO | MONDO:0044319 |
intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies |
| OMIM (phenotype) | #617452 |
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA |
| OMIM (gene) | *612021 |
OTU DOMAIN‑CONTAINING PROTEIN 6B; OTUD6B |
| Orphanet | ORPHA:505237 |
Early‑onset seizures–distal limb anomalies–facial dysmorphism–global developmental delay syndrome |
| ICD‑10 | Q87.8 |
Other specified congenital malformation syndromes NEC (via Orphanet mapping) |
| ICD‑11 | no dedicated code; nearest is LD2F "syndromes with intellectual disability as a major feature" (⚠️ not independently verified) | |
| MedGen / UMLS | C4479520 (MedGen UID 1375601) |
— |
| GARD | GARD:0017942 |
— |
| HGNC (gene) | HGNC:24281 (dismech form: hgnc:24281) |
OTU deubiquitinase 6B |
| Entrez Gene | 51633 |
— |
| Ensembl | ENSG00000155100 |
— |
| UniProt | Q8N6M0 |
Deubiquitinase OTUD6B |
| RefSeq transcript | NM_016023.5 |
reference transcript used by ClinVar |
| Cytoband | 8q21.3 |
GRCh38 chr8:91,070,196–91,087,095 |
Gene aliases: CGI-77, DUBA5; previous HGNC symbol "OTU domain containing 6B".
This is an aggregated disease‑level entity, not an EHR‑derived one. The knowledge base is built entirely from published case reports and small family series (n ≈ 28–30 individuals worldwide as of 2025), plus curated aggregators (OMIM, Orphanet, ClinGen, HPO, ClinVar). There is no registry, no natural‑history cohort, and no EHR phenotype algorithm for this disorder. The 2025 BMC Pediatrics report states verbatim:
There have been < 30 reported cases globally without fundus and retinal lesions. — Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case. BMC Pediatr. 2025 Nov 4;25(1):905 (PMID:41188742, PMC12584513)
Single, monogenic cause: biallelic (homozygous or compound heterozygous) pathogenic variants in OTUD6B. No environmental, infectious, or multifactorial etiology has been described or is biologically plausible for this entity. The etiologic mechanism is loss of function of the OTUD6B deubiquitinase, with resulting perturbation of ubiquitin‑dependent proteostasis — specifically 26S proteasome assembly/activity — during embryonic and postnatal development.
Genetic (causal): - Two pathogenic OTUD6B alleles. Reported allele classes: nonsense, frameshift, canonical splice‑site (with demonstrated aberrant splicing), and rare missense variants localized to the OTU catalytic domain. - Consanguinity is the dominant risk amplifier. Reported families are overwhelmingly consanguineous — Turkish, Egyptian (two unrelated families, PMID:34354232), Saudi/Gulf, Mexican, Spanish, Italian, Chinese. Founder/recurrent alleles: c.433C>T (p.Arg145*) was homozygous in three of the six original families and independently in the Mexican proband, consistent with either a recurrent CpG transition or a shared haplotype. - Second‑locus / blended phenotypes — an under‑appreciated etiologic modifier in this disorder. Three published probands carry a second pathogenic locus that contributes phenotype: a homozygous RP1L1 nonsense variant causing retinal degeneration in Egyptian Family I (PMID:34354232); a heterozygous PKD1 variant contributing renal cystic disease alongside Tetralogy of Fallot (PMID:35707595); and a ZMIZ1 splice variant co‑occurring with an OTUD6B point mutation + 8q21.3 microdeletion (PMID:34680978).
Environmental risk factors: none identified. No toxin, exposure, maternal factor, parity, or ascertainment‑independent sex effect has been reported.
Age/sex: onset is congenital‑to‑infantile in all reported cases. No sex bias is expected (autosomal recessive); reported cohorts include both sexes with no reported skew, though n is far too small to test.
None established. One clinically relevant gene–physiology interaction is worth flagging for the pathograph: the Chinese proband's seizures were febrile ("two episodes of febrile seizure" at 13 and 17 months, PMID:41188742) — raising a hypothesis, currently unsupported by cohort data, that intercurrent illness/pyrexia lowers seizure threshold in this proteostasis disorder. This should be curated at most as a KNOWLEDGE_GAP discussion, not as an asserted mechanism.
Retrieved from https://ontology.jax.org/api/network/annotation/OMIM:617452. Frequencies are the HPOA n/m counts, derived from the 12‑individual founding cohort (PMID:28343629) except cardiac terms, which are n/6.
| HPO ID | Term | Frequency | Notes |
|---|---|---|---|
| HP:0010864 | Severe intellectual disability | 12/12 (100%) | Core; but see §3.3 — milder alleles give mild/moderate ID |
| HP:0001250 | Seizure | 12/12 (100%) | Early‑onset |
| HP:0001263 | Global developmental delay | (not quantified) | Universal |
| HP:0000252 | Microcephaly | 9/12 (75%) | Onset HP:0003593 (Infantile onset) |
| HP:0002194 | Delayed gross motor development | 9/12 (75%) | Onset HP:0003593 |
| HP:0000750 | Delayed speech and language development | 9/12 (75%) | Absent speech in the severe group |
| HP:0001290 | Generalized hypotonia | 9/12 (75%) | |
| HP:0011968 | Feeding difficulties | 9/12 (75%) | G‑tube dependence in severe cases |
| HP:0001511 | Intrauterine growth retardation | 7/12 (58%) | Onset HP:0030674 (Antenatal onset) |
| HP:0004322 | Short stature | 7/12 (58%) | |
| HP:0000343 | Long philtrum | 7/12 (58%) | Facial gestalt |
| HP:0000400 | Macrotia | 7/12 (58%) | Facial gestalt |
| HP:0011304 | Broad thumb | 6/12 (50%) | Distal limb anomaly |
| HP:0004325 | Decreased body weight | 6/12 (50%) | |
| HP:0000219 | Thin upper lip vermilion | 6/12 (50%) | Facial gestalt |
| HP:0000637 | Long palpebral fissure | 6/12 (50%) | Kabuki‑overlap feature |
| HP:0000426 | Prominent nasal bridge | 5/12 (42%) | Facial gestalt |
| HP:0002650 | Scoliosis | 5/12 (42%) | |
| HP:0000278 | Retrognathia | 4/12 (33%) | |
| HP:0001845 | Overlapping toe | 3/12 (25%) | |
| HP:0000729 | Autistic behavior | 3/12 (25%) | |
| HP:0002079 | Hypoplasia of the corpus callosum | 3/12 (25%) | Brain MRI |
| HP:0000470 | Short neck | 3/12 (25%) | |
| HP:0002553 | Highly arched eyebrow | 3/12 (25%) | Kabuki‑overlap feature |
| HP:0200021 | Down‑sloping shoulders | 3/12 (25%) | |
| HP:0001631 | Atrial septal defect | 3/6 (50%) | Cardiac |
| HP:0001629 | Ventricular septal defect | 2/6 (33%) | Cardiac; matches the mouse |
| HP:0002510 | Spastic tetraplegia | 2/12 (17%) | Severe group |
| HP:0012450 | Chronic constipation | 2/12 (17%) | |
| HP:0000960 | Sacral dimple | 2/12 (17%) | |
| HP:0000248 | Brachycephaly | 1/12 (8%) | |
| HP:0000007 | Autosomal recessive inheritance | — | Inheritance term |
Annotated without frequency: HP:0002119 Ventriculomegaly · HP:0002540 Inability to walk · HP:0001508 Failure to thrive · HP:0001371 Flexion contracture · HP:0000028 Cryptorchidism · HP:0000369 Low‑set ears · HP:0000411 Protruding ear · HP:0000377 Abnormal pinna morphology · HP:0000365 Hearing impairment · HP:0001276 Hypertonia · HP:0000527 Long eyelashes · HP:0000218 High palate · HP:0000276 Long face · HP:0000494 Downslanted palpebral fissures · HP:0005469 Flat occiput · HP:0000431 Wide nasal bridge · HP:0001762 Talipes equinovarus · HP:0001182 Tapered finger.
| Feature | Source | Suggested HPO (⚠️ verify with just validate-terms) |
|---|---|---|
| Persistent fetal fingertip pads; broad distal phalanges of thumbs and halluces with prominent interphalangeal joints — called pathognomonic | PMID:34354232 (verbatim: "Broad distal phalanges (especially the thumbs and halluces) with prominent interphalangeal joints and fetal pads were recognized in all patients and hence considered pathognomonic.") | HP:0001212 Prominent fingertip pads; HP:0011304 Broad thumb; HP:0010511 Broad hallux |
| Orodental features: macrodontia, dental crowding, abnormally shaped teeth, thick alveolar ridges | PMID:34354232 (verbatim: "various orodental features were present including macrodontia, dental crowding, abnormally shaped teeth, and thick alveolar ridges") | HP:0001572 Macrodontia; HP:0000678 Dental crowding; HP:0006482 Abnormal dental morphology |
| Delayed eruption of primary dentition; soft doughy skin with reduced sweating; mirror movements | PMID:38389298 (verbatim: "previously unreported clinical manifestations such as delayed eruption of primary dentition, soft doughy skin with reduced sweating, and mirror movements present in our patients suggest an expansion of the phenotype") | HP:0000680 Delayed eruption of teeth; HP:0000966 Hypohidrosis; HP:0004302 Mirror movements |
| Hypothyroidism and hypogammaglobulinemia — third reported patient with both | PMID:32924626 (verbatim: "this is the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients") | HP:0000821 Hypothyroidism; HP:0004313 Decreased circulating antibody level |
| Ocular developmental anomalies: nystagmus, optic disc hypoplasia, retinal abnormalities — first report | PMID:41188742 (verbatim: "Significantly, none of the 27 previously reported IDDFSDA cases exhibited ocular developmental abnormalities.") | HP:0000639 Nystagmus; HP:0000609 Optic nerve hypoplasia |
| Tetralogy of Fallot (index case + a prior medically terminated pregnancy in the same family) | PMID:35707595 | HP:0001636 Tetralogy of Fallot |
| Renal parenchymal disease with simple cortical cysts (blended with a heterozygous PKD1 variant) | PMID:35707595 | HP:0000107 Renal cyst |
| Williams‑syndrome‑like facial features: periorbital edema, hanging cheek, long smooth philtrum; polydactyly | PMID:34680978 (verbatim: "We suggest that Williams syndrome-like phenotypes, namely, periorbital edema, hanging cheek, and long and smooth philtrum represent expanded phenotypes of OTUD6B-related ID.") | HP:0100539 Periorbital edema; HP:0000174 Abnormality of the palate; HP:0010442 Polydactyly |
| Vertebral anomaly | PMID:38389298 | HP:0003468 Abnormal vertebral morphology (⚠️ verify) |
| Brain MRI: white matter abnormalities, cortical atrophy (in addition to hypoplastic CC and ventriculomegaly) | Orphanet ORPHA:505237 summary | HP:0002500 Abnormal cerebral white matter morphology; HP:0002059 Cerebral atrophy |
| Abnormal cytoplasmic inclusions in lymphocytes (cellular phenotype) | PMC5384096 full text (⚠️ paraphrase‑risk) | no direct HPO; curate as category: Cellular |
Age of onset. Congenital‑to‑infantile. Prenatal onset is documented in a substantial minority: IUGR is annotated with HPO onset term HP:0030674 (Antenatal onset) at 7/12, and one family had a pregnancy medically terminated for antenatally diagnosed Tetralogy of Fallot (PMID:35707595). Microcephaly and motor delay carry HPO onset HP:0003593 (Infantile onset). Orphanet records age of onset as infancy. GARD summarizes symptom emergence at 1–23 months.
Severity — a genuinely bimodal distribution. This is the single most curation‑relevant characteristic of the disorder and should be modelled as has_subtypes or at minimum as an explicit severity axis:
- Severe (predicted‑null biallelic genotypes): microcephaly, absent speech, inability to walk, feeding‑tube dependence, spastic quadriplegia. MedGen summarizes: "The most severely affected patients have a neurodevelopmental disorder with microcephaly, absent speech, and inability to walk, and they require feeding tubes."
- Mild (hypomorphic missense / leaky splice): "less severely affected individuals have mild to moderate intellectual disability with normal speech and motor development." The Italian proband (PMID:30364145) is the archetype — "mild intellectual disability, speech and motor delay, and recurrent seizures."
PMID:35430327 makes the genotype→severity link explicit and computational: "our findings support that the clinical severity could be related with the predicted functional severity of the variations in OTUD6B."
Critically, intra‑familial variability also exists — PMID:34354232: "our patients showed inter- and intrafamilial differences with regard to the clinical and brain imaging findings." This argues against a purely genotype‑determined severity model and supports curating an unresolved modifier gap.
Progression. No natural‑history study exists. The disorder is best characterized as a static (non‑degenerative) encephalopathy with a congenital structural/developmental basis — brain MRI shows malformation (corpus callosum hypoplasia, ventriculomegaly) rather than progressive atrophy in most reports, though cortical atrophy is listed by Orphanet. Seizures are recurrent/episodic on a chronic lifelong background. Scoliosis and contractures are expected to be progressive secondary orthopedic complications of hypotonia/spasticity. This progression characterization is an inference from the reported feature set, not a cited finding — flag as a knowledge gap.
Frequency evidence discipline. Per docs/frequency-evidence-guidelines.md, the HPOA n/12 counts are derived counts from the founding cohort and are acceptable justification for FrequencyEnum bands. However, they reflect a single ascertainment‑biased cohort of predominantly severe cases; frequencies for the mild end of the spectrum are almost certainly overstated (e.g., "Severe intellectual disability 12/12" is contradicted by later mild cases). Recommend curating the HPOA frequencies with an explicit note, or omitting frequency: for terms where the 2018–2025 literature conflicts with the 2017 cohort.
Quality of life. No EQ‑5D, PROMIS, SF‑36, or disease‑specific QoL instrument has been applied. The only QoL statement in the literature is a clinical aspiration, from PMID:32924626: "The current challenge with this patient is to ensure medical management of his seizures and provide him with a better quality of life." Expected QoL burden is dominated by (a) refractory seizures, (b) non‑verbal status and total care dependence in the severe group, (c) feeding‑tube dependence, and (d) caregiver burden. Mark as a knowledge gap.
OTUD6B (hgnc:24281; OMIM *612021; Entrez 51633; Ensembl ENSG00000155100; UniProt Q8N6M0), 8q21.3, reference transcript NM_016023.5. Encodes a 293‑aa cysteine‑protease deubiquitinase of the OTU family.
UniProt Q8N6M0 FUNCTION comment (verbatim):
[Isoform 1]: Deubiquitinating enzyme that may play a role in the ubiquitin-dependent regulation of protein synthesis, downstream of mTORC1. May associate with the protein synthesis initiation complex and modify its ubiquitination to repress translation. May also repress DNA synthesis and modify different cellular targets thereby regulating cell growth and proliferation. May also play a role in proteasome assembly and function. [Isoform 2]: Stimulates protein synthesis. Influences the expression of CCND1/cyclin D1 by promoting its translation and regulates MYC/c-Myc protein stability.
Domain architecture: N‑terminal coiled‑coil region + OTU catalytic domain, residues 147–284. Catalytic triad residues: Cys155/Cys158 (Cys158 is the nucleophile), His277. Cys→Ser mutation of the nucleophile abolishes DUB activity (functionally demonstrated in PMID:21267069: "Mutation of the conserved Cys residue abolished its deubiquitinating activity in vitro.").
Two functionally opposed splice isoforms. Isoform 2 (OTUD6B‑2) differs by replacement of residues 1–105 with "MISK." This is not a curatorial footnote — the isoforms have antagonistic effects on translation (PMID:27864334, §6.2), which is relevant to interpreting variant consequence: a variant in exon 1–3 may affect only OTUD6B‑1.
| Metric | Value | Interpretation |
|---|---|---|
| pLI | 0 | Not LoF‑intolerant in the heterozygous state |
| LOEUF | 1.48 | Far above the 0.35 haploinsufficiency threshold |
| DECIPHER %HI | 30.63 | Moderate, but not a haploinsufficiency signal |
These metrics are exactly what is expected for a recessive disease gene and should not be read as evidence against pathogenicity. Heterozygous carriers (including all obligate parents in the reported families) are unaffected. This is an important curation point: an automated pipeline keying on pLI would incorrectly deprioritize OTUD6B.
Classification: DEFINITIVE. ClinGen (search.clinicalgenome.org/kb/genes/HGNC:24281) records one gene‑disease validity assertion:
MONDO:0000508)No ClinGen dosage‑sensitivity, actionability, or variant‑pathogenicity curations exist for this gene. No CPIC/PharmGKB records. → A CGGV: structured‑source citation should be retrievable for this assertion via just clingen-refresh / just clingen-list.
All in NM_016023.5 numbering. Zygosity as reported.
| cDNA | Protein | Class | Zygosity | Family / population | Source |
|---|---|---|---|---|---|
| c.433C>T | p.Arg145* | nonsense | homozygous | Families 1, 2, 3 (2017 cohort); independently the first Mexican proband | PMID:28343629; PMID:32924626 |
| c.469_473delTTAAC | p.Leu157Argfs*8 | frameshift | homozygous | Family 4 (2017) | PMID:28343629 |
| c.173−2A>G | — (splice acceptor) | canonical splice | homozygous | Family 5 (2017) | PMID:28343629 |
| c.647A>G | p.Tyr216Cys | missense (OTU domain) | homozygous | Family 6 (2017); milder phenotype | PMID:28343629; modelled PMID:35430327 |
| c.324+1G>C | — | splice donor, exon 2 | compound het (with below) | Italian proband; mild ID | PMID:30364145 |
| c.405+1G>A | — | splice donor, exon 3 | compound het (with above) | Italian proband | PMID:30364145 |
| c.271C>T | p.Gln91Ter | nonsense | homozygous | Egyptian Family I | PMID:34354232 |
| c.767G>T | p.Gly256Val | missense (OTU domain) | homozygous | Egyptian Family II | PMID:34354232 |
| c.873delA | p.Lys291AsnfsTer3 | frameshift | hemizygous (in trans with a paternal 0.118 Mb 8q21.3 deletion, chr8:92,084,087–92,202,189) | 5‑yr‑old girl; also carried ZMIZ1 c.1491+2T>C | PMID:34680978 |
| c.815T>G | p.Ile272Arg | missense (OTU domain) | homozygous | Tetralogy of Fallot proband; also het PKD1 variant | PMID:35707595 |
| p.Ile274Arg (cDNA not stated in abstract) | p.Ile274Arg | missense (OTU domain) | compound het with a novel frameshift | severe IDDFSDA index case | PMID:35430327 |
| c.479A>G | p.Tyr160Cys | missense (likely pathogenic) | compound het (with below) | first Chinese case; ocular anomalies + hypothyroidism | PMID:41188742 |
| c.83−1delG | — (splice acceptor) | pathogenic splice | compound het (with above) | first Chinese case | PMID:41188742 |
| (2 variants, not specified in abstract) | — | — | biallelic | 3 siblings, Kabuki‑syndrome‑like presentation | PMID:38389298 |
| (not specified in abstract) | — | — | biallelic | first Spanish case | PMID:31147255 |
ClinVar (NM_016023.5) additional P/LP small variants not tied to a specific publication above, confirmed by esummary:
- c.287del (p.Pro96fs) — Pathogenic — IDDFSDA
- c.776C>G (p.Ser259Ter) — Pathogenic
- c.381_388del (p.Leu127fs) — Pathogenic — IDDFSDA
- c.401A>G (p.Glu134Gly) — Likely pathogenic — IDDFSDA
- c.83-1del — Pathogenic — IDDFSDA (matches PMID:41188742)
ClinVar counts (2026‑08‑01, via E‑utilities): 151 total records for OTUD6B; 54 records classified P/LP. Important caveat: the majority of the 54 are large chromosome‑8 copy‑number gains/losses that merely span the locus, not gene‑level small variants. The number of distinct P/LP small OTUD6B variants is on the order of 10–15. Do not cite "54 pathogenic OTUD6B variants" without this qualification.
Variant spectrum summary: - Class distribution: nonsense ≈ 4; frameshift ≈ 4; canonical splice ≈ 4; missense ≈ 5 (all within or adjacent to the OTU domain: Tyr160, Tyr216, Gly256, Ile272/274 — plus Glu134 just N‑terminal); one whole‑gene microdeletion in trans with a point mutation. - Missense clustering in the OTU domain (147–284) is a notable pattern supporting a domain‑restricted missense hotspot and useful for PM1‑type ACMG evidence. - Somatic vs germline: all disease variants are germline. Somatic OTUD6B alteration is not a described mechanism in this disorder; OTUD6B's cancer roles (§6.2) are expression‑level, not mutational. - Allele frequency: all reported disease alleles are absent or ultra‑rare in gnomAD. PMID:30364145 states verbatim: "Both variants are reported in the GnomAD database with a frequency lower than the 10‑5 and affect the donor splicing site, of exons 2 and 3, respectively." - Functional consequence: loss of function throughout. Nonsense/frameshift alleles are predicted to trigger NMD (explicitly modelled in PMID:35430327: "The truncating frameshift variant in one allele was predicted to undergo degradation via nonsense-mediated decay of the mRNA molecule."); splice alleles cause exon skipping with near‑total loss of wild‑type transcript; missense alleles cause fold destabilization of varying severity. No gain‑of‑function or dominant‑negative mechanism has been proposed.
PMID:30364145 provides the strongest direct RNA evidence in the disorder:
RT-PCR experiments demonstrated that both variants affect OTUD6B splicing and lead to the production of aberrant transcripts, the major ones being, in both cases, the skipping of the upstream exon. Quantitative analysis performed by competitive-fluorescent RT-PCR on the patient RNA showed that the proband presents less than 1% of wild-type transcripts, further strengthening the causative role of these variants.
Not applicable. OTUD6B‑related neurodevelopmental disorder is a fully penetrant monogenic recessive condition. There are no reported environmental factors, lifestyle factors, toxicant exposures, or infectious agents that cause, trigger, or modify this disorder. No CTD/TOXNET association exists.
Two peripheral points worth recording as non‑etiologic: - The febrile trigger for the two seizures in the 2025 Chinese case (PMID:41188742) is a symptom‑precipitant observation, not an environmental etiology. - OTUD6B has documented antiviral innate‑immunity roles (§6.6). Whether patients with biallelic LoF have altered antiviral responses has not been tested in humans and must not be asserted. The reported hypogammaglobulinemia in three patients (PMID:32924626) is the only human immune signal.
This is the only mechanism established in patient material and should be the backbone of the pathograph.
Causal chain (patient‑derived, PMID:28343629):
Biallelic LoF OTUD6B variant [MOLECULAR]
→ Loss of OTUD6B deubiquitinase activity [MOLECULAR]
→ Reduced incorporation of 19S regulatory-particle subunits into 26S proteasomes;
accumulation of 19S precursor complexes [MOLECULAR]
→ Decreased 26S chymotrypsin-like peptidase activity [MOLECULAR]
→ Accumulation of ubiquitin-protein conjugates; cytoplasmic inclusions in lymphocytes [CELLULAR]
→ Impaired proteostasis in developing neural, cardiac and skeletal tissue [TISSUE]
→ Multisystem developmental disorder [ORGANISM]
The abstract‑level evidence sentence (verbatim, PMID:28343629): "Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates."
Quantitative detail from the full text (PMC5384096) — ⚠️ paraphrase‑risk, verify before citing as snippets: - Native PAGE: "substantially reduced incorporation of Rpn5 and Rpt6 subunits into 26S proteasomes," with Rpn5 reduced by ~65% (heterozygote) and ~90% (homozygote) vs. wild‑type. - 26S chymotrypsin‑like activity reduced ~20% in homozygote vs. heterozygote. - "19S precursor complexes accumulate in both heterozygous and homozygous subjects but not in wild-type controls." - Ubiquitin‑protein conjugates "accumulated much stronger in the homozygous sample than in the heterozygous one." - Proposed mechanism (authors' speculation, flagged as such in the paper): "any impaired de-ubiquitination of proteasome subunits (including Rpn10, Rpn13, or Rpt5) might impact proteasome assembly and/or function," as "formation of 26S complexes is a process regulated by ubiquitin modification."
Note the gene‑dosage gradient: heterozygous carriers show intermediate biochemical abnormality (19S precursor accumulation, 65% Rpn5 reduction) while remaining clinically unaffected. This is a clean example of a biochemical phenotype that is subclinical in carriers — useful for a biochemical marker node with a carrier‑vs‑affected interpretation band.
PMID:27864334 (in vitro, NSCLC cells) established the second major cellular function, verbatim:
Here, evidence is presented that the deubiquitinase OTUD6B regulates protein synthesis in non-small cell lung cancer (NSCLC) cells, operating downstream from mTORC1. OTUD6B associates with the protein synthesis initiation complex and modifies components of the 48S preinitiation complex. The two main OTUD6B splicing isoforms seem to regulate protein synthesis in opposing fashions: the long OTUD6B-1 isoform is inhibitory, while the short OTUD6B-2 isoform stimulates protein synthesis. […] OTUD6B-2 influences the expression of cyclin D1 by promoting its translation while regulating (directly or indirectly) c-Myc protein stability.
Relevance to the NDD: mTORC1‑coupled translational control is a canonical neurodevelopmental/epilepsy axis (cf. tuberous sclerosis, PMSE, focal cortical dysplasia). This provides a mechanistically coherent — but not experimentally demonstrated in neurons — bridge from OTUD6B loss to cortical malformation and seizure. Curate as a mechanistic_hypotheses entry with status: EMERGING, and attach the causal edge to that hypothesis group. Do not assert it as established human disease mechanism.
Two independent lines: - PMID:21267069 (mouse Ba/F3 cells + primary B lymphocytes): "Enforced expression of OTUD-6B in Ba/F3 cells could block cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was overexpressed." Also documents post‑transcriptional control — Otud-6b mRNA is destabilized by tristetraprolin (TTP) via AU‑rich elements. - PMID:36059274 (multiple myeloma, EMBO J 2022): "we screened for DUB vulnerabilities in multiple myeloma […] and identified OTUD6B as an oncogene that drives the G1/S-transition. LIN28B, a suppressor of microRNA biogenesis, is specified as a bona fide cell cycle-specific substrate of OTUD6B. Stabilization of LIN28B drives MYC expression at G1/S, which in turn allows for rapid S-phase entry."
Note the direction conflict: OTUD6B overexpression is anti‑proliferative in B lymphocytes (2011) but pro‑proliferative via LIN28B‑MYC in myeloma (2022) and isoform‑dependent in NSCLC (2017). OTUD6B's proliferative effect is therefore context‑ and isoform‑dependent, and it is not safe to infer a single direction of effect on neural progenitor proliferation. This is a legitimate KNOWLEDGE_GAP for the NDD pathograph: does OTUD6B loss reduce or expand the neural progenitor pool, and is microcephaly proliferative or apoptotic in origin?
PMID:41651815 (Cell Death Dis 2026), verbatim:
By combining interactomic and proximity proteomic approaches, we reveal that the deubiquitinating enzyme OTUD6B is associated with SG-related functions. Immunofluorescence assays showed that OTUD6B localized to SGs, as well as regulated their early assembly and clearance, partially dependent on its enzymatic activity. Further proximity proteomics and interactomics results uncover the ATPase VCP/p97, a key SG disassembly factor, as an OTUD6B-associated protein. OTUD6B and VCP association is governed through their disordered regions normally participated in biomolecular condensation. VCP knockdown or pharmacological inhibition phenocopied OTUD6B silencing by leading to defects in SG dynamics. […] Therefore, our findings establish OTUD6B as a critical modulator of SG dynamics, linking its function to stress responses and potential disease mechanisms.
The same abstract notes: "Impaired SG disassembly is closely implicated in neurodegenerative diseases and aging." Since VCP itself is a Mendelian neurodegeneration gene (MSP1/IBMPFD, ALS/FTD), an OTUD6B–VCP condensate axis is a plausible neural mechanism. Caveat: this work is in non‑neuronal cell lines and makes no claim about IDDFSDA. Curate as EMERGING hypothesis + IN_VITRO evidence source.
PMID:32328410 (Adv Sci 2020) and PMID:32323143 (Protein Cell 2020) independently show OTUD6B stabilizes pVHL without using its catalytic activity, verbatim from PMID:32328410:
OTUD6B directly interacts with pVHL, decreases its ubiquitylation and proteasomal degradation to reduce HIF-1α accumulation in HCC cells under hypoxia. Surprisingly, OTUD6B limits the ubiquitylation of pVHL independent of its deubiquitylase activity. OTUD6B couples pVHL and elongin B/C to form more CBCVHL ligase complex, which protects pVHL from proteasomal degradation. […] Furthermore, OTUD6B gene is a direct transcriptional target of HIF-1α and upregulated upon hypoxia.
Curation implication: this is why catalytically‑dead missense variants may not fully phenocopy null alleles — OTUD6B has at least one non‑catalytic scaffolding function. This directly bears on interpreting the mild p.Tyr216Cys phenotype. It also predicts that OTUD6B loss should raise HIF‑1α — a testable but untested hypothesis in patient tissue.
| Function | Substrate/partner | Evidence | Species | PMID |
|---|---|---|---|---|
| Type I IFN antiviral response — positive regulator | IRF3 (removes K33‑linked polyUb at Lys315) | in vitro + mouse | human | 37650650 |
| Antiviral response — negative regulator | irf3/irf7 (suppresses traf6‑mediated K63 polyUb) | zebrafish KO, in vivo | zebrafish | 34183367 |
| Centrosome clustering / mitotic fidelity | KIFC1/HSET (prevents premature mitotic degradation) | siRNA + CRISPR, TNBC | human | 39789388 |
| DUB–DUB heterotypic interaction | OTUB1 (first direct demonstration) | GFP‑Trap + AlphaScreen | human | 33421002 |
| Pulmonary arterial hypertension | Calpain‑1/HIF‑1α | rodent | rat/mouse | 38878112 |
| Diabetic atherosclerosis / angiogenesis | (loss → increased angiogenesis) | in vivo | mouse | 36200061 |
⚠️ The human vs. zebrafish IRF3 direction is explicitly contradictory — PMID:37650650 says so directly: "unlike the previous report that zebrafish OTUD6B negatively regulates the antiviral response by suppressing K63-linked ubiquitination of IRF3 and IRF7, we demonstrate that human OTUD6B actually enhances type I IFN response." This is a textbook HUMAN_MODEL_MISMATCH discussion candidate.
GO biological process / molecular function — all verified against OLS:
| CURIE | Label | Node |
|---|---|---|
GO:0004843 |
cysteine-type deubiquitinase activity | Loss of OTUD6B DUB activity (MF; modifier: DECREASED) |
GO:0016579 |
protein deubiquitination | Loss of OTUD6B DUB activity |
GO:0043248 |
proteasome assembly | Impaired 19S→26S proteasome assembly (DECREASED) |
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process | Reduced proteasomal degradation (DECREASED) |
GO:0034063 |
stress granule assembly | Stress granule dynamics (EMERGING hypothesis) |
GO:0002183 |
cytoplasmic translational initiation | mTORC1-coupled translation dysregulation (EMERGING) |
GO:0007507 |
heart development | Septation defect node (supported by mouse VSD + human ASD/VSD/ToF) |
⚠️ Verify with OAK before use (uv run runoak -i sqlite:obo:go info <ID> -O obo): GO:0031929 TOR signaling; GO:0007420 brain development; GO:0021987 cerebral cortex development; GO:0006915 apoptotic process.
Cell types (CL) — ⚠️ all require OAK verification: CL:2000001 peripheral blood mononuclear cell (the only cell type with direct patient‑derived experimental data) · CL:0000540 neuron · CL:0000127 astrocyte (HPA: "Subsets of astrocytes show general, distinct and intense staining throughout the brain") · CL:0000121 Purkinje cell (HPA: somato‑dendritic staining) · CL:0000746 cardiac muscle cell · CL:0000542 lymphocyte (cytoplasmic inclusions).
Primary (directly and consistently affected):
- Central nervous system — the dominant organ system. Cortex (ID, seizures, autistic behavior), corpus callosum (hypoplasia 3/12), ventricular system (ventriculomegaly), white matter, with reported cortical atrophy. UBERON:0000955 brain; UBERON:0002336 corpus callosum (verified); UBERON:0000956 cerebral cortex (⚠️ verify); lateral ventricle (⚠️ verify ID).
- Musculoskeletal system — hands and feet (broad distal phalanges, tapered fingers, clubfoot, overlapping toes, polydactyly), vertebral column (scoliosis, vertebral anomaly), joints (flexion contractures).
- Craniofacial complex — the recognizable gestalt; brachycephaly, flat occiput, retrognathia, high palate, ears (macrotia, low‑set, protruding).
- Heart — septal defects (ASD 3/6, VSD 2/6) and conotruncal malformation (Tetralogy of Fallot). Interventricular/interatrial septum are the specific sites; the mouse model independently confirms septation as the vulnerable structure.
Secondary / less consistent: - Gastrointestinal tract (feeding difficulties, chronic constipation) - Genitourinary (cryptorchidism; renal cortical cysts in one blended‑phenotype case) - Thyroid gland (hypothyroidism, ≥3 patients) - Immune system (hypogammaglobulinemia, ≥3 patients) - Eye — optic disc, retina (single case, 2025) - Ear/auditory (hearing impairment) - Teeth/oral (macrodontia, dental crowding, delayed eruption, thick alveolar ridges) - Skin/adnexa (soft doughy skin, hypohidrosis; long eyelashes)
Body systems involved: nervous, cardiovascular, musculoskeletal, digestive, endocrine, immune, genitourinary, integumentary, special senses. This breadth is expected for a defect in a ubiquitously expressed proteostasis enzyme and is why the disorder was framed from the outset as "multisystemic."
Human Protein Atlas (ENSG00000155100): OTUD6B has low tissue specificity — "Detected in all," tau specificity score 0.24, clustered as "Non-specific — Basic cellular processes." Protein‑level tissue enhancement is noted in cerebral cortex and lymphoid tissue. Within brain, HPA reports immunoreactivity in astrocytes ("Subsets of astrocytes show general, distinct and intense staining throughout the brain"), cerebellar Purkinje cells (somato‑dendritic staining), and choroid plexus cells, across hippocampal formation, cerebral cortex, and cerebellum.
The mouse Otud6b^tm1b^ lacZ reporter independently confirmed near‑ubiquitous expression: per PMC5384096 full text (⚠️ verify), lacZ expression was "nearly ubiquitous" across cardiovascular, nervous, digestive, and musculoskeletal systems.
Implication for curation: there is no evidence for a tissue‑restricted or cell‑type‑restricted primary lesion. The tissue distribution of disease reflects differential vulnerability to proteostasis failure (post‑mitotic neurons, rapidly proliferating embryonic cardiac/limb mesenchyme) rather than restricted gene expression. Model this explicitly rather than implying neural‑specific expression.
GO:0005829, ⚠️ verify) — HPA reports cytoplasmic localization; primary site of proteasome assembly and translation initiation.GO:0000502, ⚠️ verify) / proteasome regulatory particle — the site of the demonstrated 19S assembly defect.GO:0010494, ⚠️ verify) — demonstrated OTUD6B localization (PMID:41651815).Findings are bilateral and symmetric throughout: microcephaly, corpus callosum hypoplasia (a midline structure), bilateral ventriculomegaly ("mild irregular enlargement of the bilateral lateral ventricles," PMID:41188742), symmetric distal limb anomalies of both hands and feet, and midline septal cardiac defects. No lateralized or asymmetric presentation is reported. Note: the bilateral hand+foot involvement pattern makes this a candidate — though not a demonstrated one — for comparison against the limb_digit_patterning_serial_homology module; but OTUD6B is a proteostasis gene, not a limb‑patterning morphogen, so conformance would be phenotypic rather than mechanistic and is not recommended without evidence.
HP:0030674); congenital heart defects detectable prenatally (one family terminated a pregnancy for antenatally diagnosed ToF, PMID:35707595); congenital brain malformations.HP:0003593 Infantile onset), nystagmus (detected at 6 months in the Chinese case).No formal staging system, no natural‑history study, no longitudinal cohort exists. What can be stated:
⚠️ Flag: everything in §8.2–8.3 beyond the mouse data is inference. This section is the weakest‑evidenced part of the entity and should carry an explicit KNOWLEDGE_GAP discussion for natural history.
| Measure | Value | Source |
|---|---|---|
| Prevalence | <1 / 1,000,000 | Orphanet ORPHA:505237 |
dismech prevalence_class |
BELOW_1_IN_1000000 |
derived from Orphanet band |
dismech measure_type |
POINT_PREVALENCE |
Orphanet convention |
rate_per_100000 |
<0.1 | 1/1,000,000 → 0.1 per 100,000 |
| Cases in literature | ≈28–30 worldwide (2025) | PMID:41188742 (verbatim: "There have been < 30 reported cases globally…"); the 2025 paper's Table 1 tabulates 27 previously reported cases + 1 index = 28 |
| Incidence | Not established | — |
An alternative dismech Prevalence record with measure_type: CASES_IN_LITERATURE and rate_per_100000 omitted would faithfully capture the ~28‑case count; use the Orphanet band for the population rate.
HP:0000007). Confirmed by ClinGen Definitive curation (AR), OMIM, Orphanet, and segregation in every reported family (both parents heterozygous carriers). GARD states the standard recurrence figures: "there is a 25% chance their child will have the disease and a 50% chance the child will be a carrier."There is no biochemical screening test, no biomarker, and no functional assay in clinical use for this disorder. Diagnosis is molecular. Supporting/complication‑detection investigations:
| Modality | Finding | Purpose |
|---|---|---|
| Brain MRI | Corpus callosum hypoplasia, ventriculomegaly, white‑matter abnormalities, cortical atrophy; "mild irregular enlargement of the bilateral lateral ventricles" (PMID:41188742) | Characterize structural CNS involvement; supports the diagnosis but is non‑specific |
| EEG | Required for seizure characterization | No OTUD6B‑specific EEG signature has been described |
| Echocardiography | ASD, VSD, Tetralogy of Fallot | Mandatory at diagnosis — CHD in ~33–50% |
| Thyroid function tests (TSH, fT4) | Hypothyroidism in ≥3 patients | PMID:32924626 explicitly recommends screening: "underscoring the value of screening for these conditions in other patients" |
| Serum immunoglobulins (IgG, IgA, IgM) | Hypogammaglobulinemia in ≥3 patients | Same recommendation |
| Ophthalmological exam incl. fundoscopy | Optic disc hypoplasia, retinal abnormalities, nystagmus (1 case) | Newly recommended by PMID:41188742 |
| Audiological assessment | Hearing impairment (HPO‑annotated) | Standard for syndromic ID |
| Spine radiographs | Scoliosis, vertebral anomaly | Surveillance |
| Renal ultrasound | Cortical cysts (1 case, confounded by PKD1) | Consider |
| Growth monitoring | IUGR, short stature, failure to thrive | Ongoing |
Research‑only cellular assays (not clinically available, but of high mechanistic value — and the basis of any future functional‑evidence framework for VUS interpretation): - Native PAGE of PBMC lysates for 19S/26S proteasome assembly (Rpn5, Rpt6 incorporation) - 26S chymotrypsin‑like peptidase activity assay - Anti‑ubiquitin immunoblot for ubiquitin‑protein conjugate accumulation - Light microscopy for cytoplasmic lymphocyte inclusions
Biopsy/histopathology: no diagnostic biopsy indicated; no characteristic histopathology described beyond the lymphocyte inclusions.
No LOINC‑coded disease‑specific test exists.
Recommended approach: trio exome or genome sequencing, with parallel or reflex chromosomal microarray.
| Modality | Utility | Notes |
|---|---|---|
| Trio WES | First‑line; highest yield. Every published diagnosis except one was made by exome sequencing | PMID:41188742 used "TrioWES"; PMID:34680978, 35430327, 35707595, 32924626, 30364145 all WES |
| WGS | Useful when WES is negative but suspicion is high | Would capture deep‑intronic and structural events; no published OTUD6B case required WGS |
| Chromosomal microarray (CMA) | Essential adjunct, not optional. One reported case required CMA to find the second allele — a 0.118 Mb 8q21.3 deletion in trans with a point mutation (PMID:34680978) | A WES‑only workflow would have reported this patient as a heterozygous carrier and missed the diagnosis |
| Gene panels | OTUD6B is included on broad ID/epileptic‑encephalopathy/NDD panels | Panel content varies; confirm inclusion |
| Single‑gene testing | Justified only for targeted familial testing or where the clinical gestalt is strongly recognizable in a consanguineous family — PMID:34354232's Family II used "targeted sequencing" after clinical suspicion | Not a first‑line strategy |
| RNA studies (RT‑PCR / competitive‑fluorescent RT‑PCR) | High value for splice variants. The single best functional evidence in the literature (PMID:30364145) came from patient‑RNA quantification | Should be pursued for any canonical or near‑splice VUS |
| Karyotyping / FISH | No role — the reported deletion (0.118 Mb) is far below karyotype resolution | |
| mtDNA testing | No role | |
| Repeat expansion testing | No role |
Critical WES‑interpretation caveat, twice demonstrated: in consanguineous families, a second homozygous recessive disorder may coexist and confound phenotyping. PMID:34354232 found homozygous RP1L1 nonsense variants explaining retinal degeneration that had initially been attributed to OTUD6B; PMID:35707595 found a heterozygous PKD1 variant explaining renal cysts. Do not attribute every feature in a proband to OTUD6B without checking the rest of the exome.
No formal consensus diagnostic criteria exist (no society guideline, no DSM/ICD operational criteria, no GeneReviews chapter as of this review). Diagnosis = compatible phenotype + biallelic pathogenic OTUD6B variants.
A clinically recognizable gestalt is claimed but contested. PMID:38389298 puts it precisely: "Physical differences described for affected individuals suggest that the disorder may be clinically recognizable, but previous publications have reported an initial clinical suspicion for Kabuki syndrome (KS) in some affected individuals." The most specific reported sign is from PMID:34354232 — broad distal phalanges of thumbs and halluces with prominent interphalangeal joints and persistent fetal pads, described as "pathognomonic." (⚠️ "Pathognomonic" is the authors' assertion from a 5‑patient, 2‑family series; treat as a strong clinical pearl, not an established specificity claim.)
Differential diagnosis — each entry below is grounded in an actual published misdiagnosis or clinical suspicion, which makes this an unusually well‑evidenced DDx:
| Condition | Overlapping features | Discriminator |
|---|---|---|
| Kabuki syndrome (KMT2D, KDM6A) | Long palpebral fissures, prominent/cupped ears, persistent fetal fingertip pads, DD, growth deficiency, vertebral anomaly, seizures — documented initial clinical diagnosis in ≥2 reports (PMID:38389298, PMID:30364145) | Inheritance (KS is AD/XL vs. AR); KMT2D/KDM6A episignature; eversion of the lower lateral eyelid |
| Rubinstein–Taybi syndrome (CREBBP, EP300) | Broad thumbs and halluces, ID, dysmorphism — the Italian proband "came to our attention after being screened for genes responsible for Rubinstein-Taybi syndrome" (PMID:30364145) | AD vs. AR; RTS broad thumbs are typically angulated; PMID:30364145 explicitly recommends screening OTUD6B in RTS‑suspected, RTS‑gene‑negative patients |
| Williams–Beuren syndrome (7q11.23 del) | Periorbital edema, hanging cheek, long smooth philtrum, cardiac defect, DD — "facial phenotypes resembling Williams syndrome" (PMID:34680978) | CMA; supravalvar aortic stenosis; hypercalcemia; social phenotype |
| ZMIZ1‑related NDD | ID, facial dysmorphism, distal limb anomalies, seizures — PMID:34680978 notes "shared phenotypes of facial dysmorphism, distal limb anomalies, and seizure disorders" | AD vs. AR |
| Cornelia de Lange syndrome | IUGR, microcephaly, limb anomalies, ID, arched eyebrows, long eyelashes | Synophrys; upper‑limb reduction defects; cohesinopathy genes |
| Other proteostasis/DUB NDDs — OTUD7A (15q13.3), and proteasome‑associated disorders | ID + epilepsy + DUB/UPS mechanism | Gene identity; OTUD7A is AD/CNV‑driven at 15q13.3 |
| Other AR syndromic ID with seizures (broad category) | Overlapping core | Requires ES/GS |
⚠️ This section is the most evidence‑poor in the report. There is no survival study, no mortality figure, no life‑expectancy estimate, no disability‑outcome measure, and no validated prognostic model for OTUD6B‑related disorder. What follows distinguishes the few citable facts from clinical inference.
HUMAN_MODEL_MISMATCH — model it as such, not as a survival prediction.Documented: recurrent seizures; feeding failure and aspiration risk; failure to thrive/short stature; congenital heart disease and its sequelae; progressive scoliosis and contractures; hypothyroidism; hypogammaglobulinemia (with attendant infection risk); hearing impairment; visual impairment (single case); constipation.
Recovery potential: none for the core neurodevelopmental phenotype. Developmental gains occur but the underlying encephalopathy is not reversible with any current intervention. Treatable comorbidities (hypothyroidism, seizures, CHD, nutrition) are the domains where intervention changes outcome.
The only supported prognostic factor is genotype severity class: - Biallelic predicted‑null (nonsense/frameshift/canonical splice, both alleles) → severe phenotype - Hypomorphic missense or leaky splice on ≥1 allele → milder phenotype
PMID:35430327 formalized this with molecular‑dynamics modelling: p.Tyr216Cys (mild) → "localized destabilization"; p.Ile274Arg (severe) → "significant distortion in the overall fold of OTUD6B." Its own conclusion is appropriately hedged: "However, additional functional studies are required."
Additional plausible but unvalidated prognostic markers: presence/severity of microcephaly; age at seizure onset and seizure control; presence of CHD; degree of structural brain malformation on MRI. None is validated.
Prognostic biomarkers: none. The proteasome‑assembly assay is a candidate quantitative severity readout (given the observed WT < het < hom gradient) but has never been correlated with clinical outcome. This is a concrete, tractable research proposal worth recording as a proposed_experiments item.
There is no disease‑modifying, targeted, or curative therapy for OTUD6B‑related neurodevelopmental disorder. Management is entirely symptomatic, supportive, and anticipatory. No clinical trial has ever been registered for this disorder (ClinicalTrials.gov search: no OTUD6B‑specific trials). No FDA/EMA‑approved therapy exists. No pharmacogenomic guidance (CPIC/PharmGKB: zero high‑level records for OTUD6B, per ClinGen).
The literature contains no treatment protocol; the closest statement of intent is PMID:32924626: "The current challenge with this patient is to ensure medical management of his seizures and provide him with a better quality of life. The possibilities of additional therapeutic approaches may increase by understanding the physiopathology of the involved pathways."
⚠️ All NCIT IDs below require verification (uv run runoak -i sqlite:obo:ncit info <ID> and just validate-terms). They are supplied as curation candidates, not verified bindings. Treatments in this section are standard‑of‑care inferences for syndromic ID with epilepsy, not OTUD6B‑specific published recommendations — this must be stated explicitly in any KB entry.
| Intervention | treatment_term (NCIT, ⚠️ verify) |
therapeutic_modality |
Basis |
|---|---|---|---|
| Antiseizure medication | NCIT:C15986 Pharmacotherapy |
SMALL_MOLECULE |
Universal (seizures 12/12). No agent‑specific data; no evidence any ASM class is preferentially effective. therapeutic_agent should be left generic unless a specific drug is documented per patient. |
| Levothyroxine replacement | NCIT:C15986 Pharmacotherapy |
SMALL_MOLECULE |
For the documented hypothyroidism subgroup (PMID:32924626, PMID:41188742). therapeutic_agent: levothyroxine (CHEBI, ⚠️ verify) |
| Immunoglobulin replacement | NCIT:C15986 Pharmacotherapy |
OTHER/PROTEIN_REPLACEMENT |
Consider for symptomatic hypogammaglobulinemia (PMID:32924626). ⚠️ No published case reports IVIG use — this is inference. |
| Cardiac surgical repair (septal defect closure; ToF repair) | NCIT:C15329 Surgical Procedure |
SURGERY |
CHD in 33–50%; ToF documented (PMID:35707595) |
| Gastrostomy / enteral feeding | NCIT:C15747 Supportive Care or NCIT:C15433 Nutritional Support |
OTHER |
Feeding tubes explicitly required in the severe group (MedGen/OMIM summary) |
| Physical therapy | NCIT:C15302 Physical Therapy |
BEHAVIORAL |
Hypotonia, contractures, non‑ambulation |
| Occupational therapy | NCIT:C121351 Occupational Therapy |
BEHAVIORAL |
Fine motor, ADLs |
| Speech and language therapy / AAC | NCIT:C159273 Speech Therapy |
BEHAVIORAL |
Absent or delayed speech |
| Orthopedic management of scoliosis/contractures (bracing, corrective surgery) | NCIT:C16186 Orthopedic Surgical Procedure |
SURGERY |
Scoliosis 5/12 |
| Hearing aids / audiological management | (no reliable NCIT action term — see CLAUDE.md note) | DEVICE |
Hearing impairment HPO‑annotated |
| Ophthalmological / low‑vision management | NCIT:C49236 Therapeutic Procedure |
— | Nystagmus, optic disc hypoplasia (1 case) |
| Genetic counseling | NCIT:C15240 Genetic Counseling |
— | AR 25% recurrence; consanguinity counselling |
| Early intervention / developmental services | NCIT:C15315 Rehabilitation |
BEHAVIORAL |
Standard for syndromic ID |
| Modality | Status |
|---|---|
| Gene therapy (AAV gene replacement) | None. Not in preclinical development. OTUD6B's small coding sequence (293 aa, ~882 bp) makes it AAV‑tractable in principle, but the disorder's largely prenatal/early‑developmental onset makes postnatal CNS gene replacement of uncertain benefit. |
| Gene editing | None |
| RNA therapeutics (ASO/siRNA) | None. Notably, the two splice alleles (c.324+1G>C, c.405+1G>A) are the type of lesion sometimes amenable to splice‑switching ASO, but no such program exists and the residual‑transcript data (<1% WT) suggest an already‑near‑null substrate. |
| Cell therapy | None |
| Targeted small molecules | None. OTU‑family DUB inhibitors are an active drug‑discovery area (PMID:40527635), but that pipeline aims at inhibiting OTU DUBs in cancer — the opposite of what a loss‑of‑function disorder requires. Do not curate OTU‑targeting oncology therapeutics as candidate treatments for this disease. |
| Proteostasis modulation | Conceptually attractive (a proteasome‑assembly chaperone or activator) but entirely hypothetical; no agent identified. |
| Immunotherapy | Not applicable |
The single most useful management statement in the literature is the screening recommendation from PMID:32924626, which should be carried into the KB entry:
In addition to seizures and other more frequently reported manifestations of this condition, this is the third patient with associated hypothyroidism and hypogammaglobulinemia, underscoring the value of screening for these conditions in other patients.
To which PMID:41188742 adds ophthalmological evaluation. Baseline workup at diagnosis should therefore include: echocardiogram, brain MRI, EEG, thyroid function tests, serum immunoglobulins, ophthalmological examination with fundoscopy, audiology, and spine imaging.
Because this is a fully penetrant monogenic recessive disorder with no environmental component, prevention means reproductive genetics — not risk‑factor modification.
This is where prevention is genuinely actionable: - Systematic screening for hypothyroidism and hypogammaglobulinemia (explicitly recommended, PMID:32924626) — both are treatable and both, if missed, add avoidable morbidity. - Echocardiography at diagnosis to detect surgically correctable CHD. - Ophthalmological and audiological assessment to prevent avoidable sensory‑deprivation contributions to developmental delay. - Aspiration prevention via feeding assessment and, where indicated, gastrostomy. - Scoliosis and contracture surveillance with early orthopedic and physiotherapy intervention. - Seizure control optimization.
| Species | NCBI Taxon | Gene | Identifier | Notes |
|---|---|---|---|---|
| Homo sapiens | NCBITaxon:9606 |
OTUD6B | Entrez 51633; HGNC:24281 | 8q21.3; 293 aa |
| Mus musculus | NCBITaxon:10090 |
Otud6b | MGI:1919451 | Chr4: 14,809,503–14,826,413 (minus strand); ortholog of human chr8:91,070,196–91,087,095 |
| Danio rerio | NCBITaxon:7955 |
otud6b | ZFIN (⚠️ verify ID) | Functional antiviral studies (PMID:34183367) |
| Rattus norvegicus | NCBITaxon:10116 |
Otud6b | RGD (⚠️ verify ID) | Used in PAH studies (PMID:38878112) |
⚠️ Caution: MGI:1922805 is not Otud6b (it is Nsmce3l). Use MGI:1919451.
None reported. There is no naturally occurring OTUD6B‑related disease in any companion animal, livestock species, or wildlife population. A search of the veterinary literature and OMIA yields no OTUD6B entry (⚠️ OMIA was not directly queried in this review — verify at omia.org before asserting absence definitively).
Veterinary relevance: none. All animal OTUD6B disease models are experimentally induced, not natural.
HUMAN_MODEL_MISMATCH rather than as conflicting evidence for a single claim.Allele: Otud6b^tm1b(EUCOMM)Wtsi (MGI:5637064) — a knockout‑first tm1a converted to tm1b by Cre‑mediated excision of the promoter‑driven neo cassette and critical exon(s), leaving a lacZ reporter in place. This design is what enabled the expression mapping.
Repositories: MGI records 10 mutations/alleles for Otud6b (2 endonuclease‑mediated, 4 gene‑trapped, 4 targeted) and 29 strains/lines available through IMSR. A line is archived at MRC Harwell (B6Dnk;B6N-Otud6b^tm1b(EUCOMM)Wtsi/WtsiCnbc, stock 7042). IMPC phenotyping data at mousephenotype.org/data/genes/MGI:1919451.
Phenotype (MGI summary): "complete perinatal lethality, decreased fetal size, and ventricular septal defects," with annotations spanning cardiovascular, growth/size, hematopoietic, immune, and mortality/aging systems, from 13 phenotype references.
Detailed findings (PMC5384096 full text — ⚠️ paraphrase‑risk, verify before use as snippets): - Subviability: only 2 homozygotes identified from 97 births (p<1×10⁻⁵ deviation from Mendelian expectation); both died at birth. - Timing of lethality: homozygotes survived to E18.5 at expected frequencies → death occurs between E18.5 and shortly after birth. This is a precise and useful window. - Growth: E18.5 knockout embryos showed 34% reduced total volume vs. wild‑type littermates — a direct correlate of the human IUGR/growth restriction phenotype. - Cardiac: ventricular septal defects in 80% of hearts (3/3 at E14.5; 1/2 at E18.5) vs. a 0.67% background rate in C57BL/6N controls. - Expression: lacZ reporter expression "nearly ubiquitous," across cardiovascular, nervous, digestive, and musculoskeletal systems.
IMPC phenotyping (mousephenotype.org, MGI:1919451): 2 significant phenotypes; 3 of 21 tested physiological systems significantly impacted — mortality/aging, immune system, hematopoietic system (18 systems no significant impact, 3 not tested). Note that the immune and hematopoietic hits are independently interesting given the human hypogammaglobulinemia reports and the B‑lymphocyte cell‑cycle work (PMID:21267069).
| Human feature | Mouse recapitulation | Assessment |
|---|---|---|
| Congenital heart disease (ASD/VSD/ToF) | VSD in 80% of hearts vs. 0.67% background | Excellent — strongest cross‑species validation |
| Growth restriction / IUGR | 34% reduced embryo volume at E18.5 | Good |
| Immune involvement (hypogammaglobulinemia) | IMPC significant immune + hematopoietic impact | Suggestive |
| Intellectual disability | Not assessable — homozygotes die perinatally | Not recapitulated |
| Seizures | Not assessable — perinatal lethality | Not recapitulated |
| Microcephaly / brain malformation | Not reported | Not recapitulated / not examined |
| Survival | Perinatal lethal in mouse; survival to childhood in humans | Direct mismatch |
Limitations — this is the crux of the model problem and should be curated as an explicit HUMAN_MODEL_MISMATCH discussion:
The constitutive mouse null is too severe to model the defining features of the human disease. Because homozygotes die at birth, the model cannot address intellectual disability, seizures, speech, ambulation, microcephaly, or any postnatal neurodevelopmental outcome — i.e., the entire clinical core of IDDFSDA. What the mouse does establish is the embryonic arm: cardiac septation and fetal growth. The human null phenotype is milder than the mouse null, meaning there is either species‑specific redundancy (possibly OTUD6A or other OTU‑family paralogs) or a difference in developmental dependence on the enzyme.
Proposed experiments to resolve the mismatch (proposed_experiments candidates):
1. Conditional/neural‑specific Otud6b knockout (e.g., Nestin‑Cre, Emx1‑Cre) to bypass perinatal lethality and interrogate cortical development, seizure susceptibility, and behavior.
2. Hypomorphic knock‑in of the human missense alleles (p.Tyr216Cys as the "mild" allele; p.Ile272Arg/p.Ile274Arg as the "severe" allele) to test the genotype–severity model computationally proposed by PMID:35430327 in an in‑vivo system.
3. Patient iPSC‑derived cortical neurons and cerebral organoids — currently the most important missing model. No iPSC or organoid model of OTUD6B deficiency has been published. This would permit direct testing of the proteasome‑assembly defect in human neurons and of the mTORC1‑translation and stress‑granule hypotheses in the disease‑relevant cell type.
4. Correlate the PBMC proteasome‑assembly assay with clinical severity across a genotype‑stratified patient cohort, to test whether it functions as a quantitative severity biomarker.
| System | Use | Relevance to IDDFSDA | PMID |
|---|---|---|---|
| Zebrafish otud6b mutant/KO | Antiviral innate immunity (irf3/irf7 K63‑Ub) | Low — immune, not neurodevelopmental; and direction of effect conflicts with human | 34183367 |
| Rat (PAH model) | Calpain‑1/HIF‑1α in pulmonary hypertension | Low | 38878112 |
| Mouse Ba/F3 cells + primary B lymphocytes | Cell‑cycle G1 arrest; TTP‑mediated mRNA destabilization | Moderate — cell‑cycle mechanism | 21267069 |
| Human cancer cell lines (NSCLC, HCC, TNBC, MM, CRC, ESCC, cholangiocarcinoma) | Translation, pVHL/HIF, KIFC1/centrosome, LIN28B/MYC, stress granules | Mechanistically informative but disease‑context‑mismatched. All are IN_VITRO and none models neurodevelopment. Curate with evidence_source: IN_VITRO and explicitly note the context mismatch. |
27864334, 32328410, 39789388, 36059274, 41651815 |
| Patient PBMCs | 19S/26S proteasome assembly, chymotrypsin‑like activity, Ub‑conjugate accumulation | Highest relevance — the only patient‑derived functional system, and the source of the disease's core mechanism | 28343629 |
| iPSC / organoid | — | None published. Major gap. | — |
| Drosophila / C. elegans / yeast | — | No published OTUD6B‑ortholog disease model | — |
Model databases: MGI (informatics.jax.org/marker/MGI:1919451), IMPC (mousephenotype.org/data/genes/MGI:1919451), IMSR (29 strains), EUCOMM/EMMA, MRC Harwell (stock 7042), ZFIN, RGD, Alliance of Genome Resources.
References with verbatim abstracts captured in this report (suitable for snippet: after just fetch-reference + just validate-references):
| PMID | Year | Type | Role | evidence_source |
|---|---|---|---|---|
| 28343629 | 2017 | AJHG, original series (n=12/6 families) | Landmark — disease definition, variants, mouse, proteasome mechanism | HUMAN_CLINICAL (+ MODEL_ORGANISM, IN_VITRO for sub-claims — split the item) |
| 30364145 | 2018 | Front Genet, case | First independent replication; RT‑PCR splice functional data; Rubinstein‑Taybi DDx | HUMAN_CLINICAL |
| 31147255 | 2020 | An Pediatr, case | First Spanish case (Spanish‑language; no English abstract — cached record has no abstract text; do not fabricate a snippet) | HUMAN_CLINICAL |
| 32181568 | 2020 | AJMG A, commentary | Alkuraya comment on the AJHG paper (no abstract — cache confirms content_type: abstract_only with no abstract body; unusable as a snippet source) |
— |
| 32924626 | 2020 | JIMCRI, case | First Mexican case; hypothyroidism + hypogammaglobulinemia screening recommendation | HUMAN_CLINICAL |
| 34354232 | 2022 | J Hum Genet, 5 patients/2 families | Egyptian families; orodental features; "pathognomonic" fetal pads; RP1L1 exclusion | HUMAN_CLINICAL |
| 34680978 | 2021 | Genes, case | Point mutation + 0.118 Mb 8q21.3 microdeletion; Williams‑like features; ZMIZ1 co‑occurrence | HUMAN_CLINICAL |
| 35430327 | 2022 | EJMG, case + modelling | Genotype–severity structural/MD modelling (Tyr216Cys vs Ile274Arg) | HUMAN_CLINICAL + COMPUTATIONAL (split) |
| 35707595 | 2022 | Mol Syndromol, case | Tetralogy of Fallot; p.Ile272Arg; PKD1 blended phenotype | HUMAN_CLINICAL |
| 38389298 | 2024 | AJMG A, 3 siblings | Kabuki syndrome mimicry; delayed dentition, hypohidrosis, mirror movements | HUMAN_CLINICAL |
| 41188742 | 2025 | BMC Pediatr, case | First Chinese case; ocular dysplasia; 28‑case tabulation; "<30 reported cases globally" | HUMAN_CLINICAL |
| 27864334 | 2017 | Mol Cancer Res | mTORC1‑downstream translation; isoform antagonism; cyclin D1/c‑Myc | IN_VITRO |
| 21267069 | 2011 | PLoS One | First functional characterization; Cys‑dependent DUB activity; G1 arrest; TTP regulation | IN_VITRO + MODEL_ORGANISM |
| 36059274 | 2022 | EMBO J | OTUD6B–LIN28B–MYC axis; G1/S | IN_VITRO |
| 39789388 | 2025 | EMBO Rep | KIFC1/centrosome clustering; catalytic‑activity dependence | IN_VITRO |
| 41651815 | 2026 | Cell Death Dis | Stress granules + VCP/p97; most neurologically suggestive recent mechanism | IN_VITRO |
| 32328410 | 2020 | Adv Sci | Enzyme‑independent pVHL stabilization; HIF‑1α feedback loop | IN_VITRO |
| 33421002 | 2021 | Methods Mol Biol | First direct OTUD6B–OTUB1 interaction | IN_VITRO |
| 34183367 | 2021 | J Immunol | Zebrafish otud6b, negative antiviral regulator | MODEL_ORGANISM |
| 37650650 | 2023 | mBio | Human OTUD6B, positive antiviral regulator via IRF3 K33‑Ub — explicit contradiction with zebrafish | IN_VITRO + MODEL_ORGANISM |
| 35662507 | 2022 | Biol Psychiatry, review | "The DUB Club" — DUBs and NDDs framing | OTHER |
| 40527635 | 2026 | Trends Mol Med, review | OTU DUBs in disease and their targeting | OTHER |
Structured‑database citations available: ORPHA:505237 (Orphanet — definition, prevalence <1/1,000,000, ICD‑10 Q87.8, AR inheritance, infancy onset) and a CGGV: ClinGen gene‑disease validity record (OTUD6B / syndromic intellectual disability / AR / Definitive / ID and Autism GCEP / 2024‑08‑22). Both should be pulled through the repo's structured‑source pipeline (just structured-rebuild-orphanet --id 505237, just clingen-refresh + just clingen-list) rather than hand‑transcribed.
HUMAN_MODEL_MISMATCH.EMERGING hypotheses from non‑neuronal cells.Literature (PubMed): PMID:28343629 · PMID:30364145 · PMID:31147255 · PMID:32181568 · PMID:32924626 · PMID:34354232 · PMID:34680978 · PMID:35430327 · PMID:35707595 · PMID:38389298 · PMID:41188742 · PMID:27864334 · PMID:21267069 · PMID:36059274 · PMID:39789388 · PMID:41651815 · PMID:32328410 · PMID:33421002 · PMID:34183367 · PMID:37650650 · PMID:35662507 · PMID:40527635 · PMC5384096 (AJHG full text) · PMC12584513 (BMC Pediatr full text)
Databases and aggregators: OMIM #617452 · OMIM *612021 · Orphanet ORPHA:505237 · MedGen C4479520 · GARD 17942 · HPO annotations (ontology.jax.org) · ClinGen OTUD6B (HGNC:24281) · HGNC REST (OTUD6B) · UniProt Q8N6M0 · Human Protein Atlas ENSG00000155100 · MGI:1919451 (mouse Otud6b) · MGI:5637064 (Otud6b tm1b allele) · IMPC MGI:1919451 · MRC Harwell stock 7042 · ClinVar and PubMed queried via NCBI E‑utilities · OLS4 (EBI) for GO/UBERON/MONDO verification